0001290658 2025-01-01 2025-12-31 0001290658 2025-06-30 0001290658 2026-05-11 0001290658 2025-10-01 2025-12-31 0001290658 2025-12-31 0001290658 2024-12-31 0001290658 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesBPreferredStockMember 2024-12-31 0001290658 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesCPreferredStockMember 2024-12-31 0001290658 us-gaap:SeriesDPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesDPreferredStockMember 2024-12-31 0001290658 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001290658 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesEPreferredStockMember 2024-12-31 0001290658 2024-01-01 2024-12-31 0001290658 ITOX:PreferredStockSeriesAMember 2023-12-31 0001290658 ITOX:PreferredStockSeriesEMember 2023-12-31 0001290658 us-gaap:CommonStockMember 2023-12-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001290658 us-gaap:RetainedEarningsMember 2023-12-31 0001290658 2023-12-31 0001290658 ITOX:PreferredStockSeriesAMember 2024-12-31 0001290658 ITOX:PreferredStockSeriesEMember 2024-12-31 0001290658 us-gaap:CommonStockMember 2024-12-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001290658 us-gaap:RetainedEarningsMember 2024-12-31 0001290658 ITOX:PreferredStockSeriesAMember 2024-01-01 2024-12-31 0001290658 ITOX:PreferredStockSeriesEMember 2024-01-01 2024-12-31 0001290658 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001290658 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001290658 ITOX:PreferredStockSeriesAMember 2025-01-01 2025-12-31 0001290658 ITOX:PreferredStockSeriesEMember 2025-01-01 2025-12-31 0001290658 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-12-31 0001290658 us-gaap:RetainedEarningsMember 2025-01-01 2025-12-31 0001290658 ITOX:PreferredStockSeriesAMember 2025-12-31 0001290658 ITOX:PreferredStockSeriesEMember 2025-12-31 0001290658 us-gaap:CommonStockMember 2025-12-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001290658 us-gaap:RetainedEarningsMember 2025-12-31 0001290658 ITOX:StockIncentivePlan2017Member 2025-01-01 2025-12-31 0001290658 ITOX:StockIncentivePlan2019Member 2025-01-01 2025-12-31 0001290658 ITOX:StockIncentivePlan2017Member 2025-12-31 0001290658 ITOX:StockIncentivePlan2017Member 2024-12-31 0001290658 ITOX:StockIncentivePlan2019Member 2025-12-31 0001290658 ITOX:StockIncentivePlan2019Member 2024-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2022-03-18 0001290658 ITOX:StockIncentivePlan2022Member 2025-01-01 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2024-01-01 2024-12-31 0001290658 srt:ChiefExecutiveOfficerMember 2025-10-30 0001290658 srt:ChiefExecutiveOfficerMember 2024-12-31 0001290658 srt:ChiefExecutiveOfficerMember ITOX:SalaryPayableMember 2025-01-01 2025-12-31 0001290658 srt:ChiefExecutiveOfficerMember ITOX:ReimbursableExpensesAndIncentivesMember 2025-01-01 2025-12-31 0001290658 srt:ChiefExecutiveOfficerMember us-gaap:SeriesEPreferredStockMember 2025-01-01 2025-12-31 0001290658 srt:ChiefOperatingOfficerMember ITOX:April12024Member ITOX:StockIncentivePlan2022Member 2022-06-02 0001290658 srt:ChiefOperatingOfficerMember 2025-10-30 0001290658 srt:ChiefOperatingOfficerMember 2024-12-31 0001290658 srt:ChiefOperatingOfficerMember ITOX:SalaryPayableMember 2025-01-01 2025-12-31 0001290658 srt:ChiefOperatingOfficerMember ITOX:ReimbursableExpensesAndIncentivesMember 2025-01-01 2025-12-31 0001290658 srt:ChiefOperatingOfficerMember us-gaap:SeriesEPreferredStockMember 2025-01-01 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableAMember 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableAMember 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableDMember 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableDMember 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableEMember 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableEMember 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableAMember 2025-10-29 2025-10-30 0001290658 ITOX:ConvertibleNotesPayableAMember 2025-01-01 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableAMember 2024-01-01 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableDMember 2025-10-29 2025-10-30 0001290658 ITOX:ConvertibleNotesPayableDMember 2025-01-01 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableDMember 2024-01-01 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableEMember 2025-10-29 2025-10-30 0001290658 ITOX:ConvertibleNotesPayableEMember 2025-01-01 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableEMember 2024-01-01 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2024-01-01 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2025-01-01 2025-12-31 0001290658 us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-12-31 0001290658 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-12-31 0001290658 ITOX:VestedSharesToDirectorsAndOfficersMember 2025-01-01 2025-12-31 0001290658 ITOX:VestedSharesToDirectorsAndOfficersMember 2024-01-01 2024-12-31 0001290658 ITOX:UnvestedSharesToDirectorsAndOfficersMember 2025-01-01 2025-12-31 0001290658 ITOX:UnvestedSharesToDirectorsAndOfficersMember 2024-01-01 2024-12-31 0001290658 ITOX:TwoStockholdersMember 2025-12-31 0001290658 ITOX:TwoStockholdersMember 2024-12-31 0001290658 ITOX:StockholderMember 2025-01-01 2025-12-31 0001290658 ITOX:StockholderMember 2024-01-01 2024-12-31 0001290658 ITOX:AccruedRentMember 2025-10-29 2025-10-30 0001290658 ITOX:TwoStockholdersMember 2025-12-31 0001290658 ITOX:TwoStockholdersMember 2024-12-31 0001290658 ITOX:ConvertibleNotesPayableEMember 2025-10-30 0001290658 ITOX:EmmonsMember us-gaap:SeriesEPreferredStockMember ITOX:ConsultingAgreementMember 2025-10-29 2025-10-30 0001290658 ITOX:EmmonsMember us-gaap:SeriesEPreferredStockMember ITOX:ConsultingAgreementMember 2025-12-31 0001290658 ITOX:PaymentToVendorMember 2025-10-29 2025-10-30 0001290658 ITOX:StockIncentivePlan2017Member 2017-12-14 0001290658 ITOX:StockIncentivePlan2017Member 2025-10-30 0001290658 ITOX:StockIncentivePlan2019Member 2019-03-11 0001290658 ITOX:TwoConsultantsMember ITOX:StockIncentivePlan2019Member 2025-03-04 2025-03-05 0001290658 ITOX:StockIncentivePlan2019Member 2019-03-12 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2022-03-19 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2025-10-30 0001290658 ITOX:AnOfficerAndADirectorMember 2025-03-04 2025-03-05 0001290658 ITOX:AdvisorMember 2025-03-04 2025-03-05 0001290658 ITOX:AnOfficerADirectorMemberAndAnAdvisorMember 2025-03-04 2025-03-05 0001290658 ITOX:AnOfficerAndADirectorMember 2025-06-22 2025-06-23 0001290658 ITOX:StockIncentivePlan2022Member us-gaap:CommonStockMember 2025-01-01 2025-10-30 0001290658 us-gaap:SeriesAPreferredStockMember 2025-10-30 0001290658 ITOX:SeriesASupervotingPreferredStockMember 2025-11-05 0001290658 ITOX:CliffEmmonsMember us-gaap:SeriesAPreferredStockMember 2025-11-04 2025-11-05 0001290658 ITOX:VidMittaMember us-gaap:SeriesAPreferredStockMember 2025-11-04 2025-11-05 0001290658 ITOX:KarenMcNamerMember us-gaap:SeriesAPreferredStockMember 2025-11-04 2025-11-05 0001290658 us-gaap:SeriesBPreferredStockMember 2020-11-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2020-11-18 2020-11-19 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2020-11-19 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2020-12-15 2020-12-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2020-12-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2021-12-19 2021-12-20 0001290658 ITOX:SecuritiesPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember ITOX:IssuedDecember2021Member 2021-12-19 2021-12-20 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2022-02-06 2022-02-07 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2022-02-07 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2022-03-23 2022-03-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2022-03-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2022-11-16 2022-11-17 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2022-11-17 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2023-08-23 2023-08-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2023-08-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2024-04-15 2024-04-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2024-04-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2024-10-02 2024-10-03 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2024-10-03 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2024-01-01 2024-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2024-12-31 0001290658 us-gaap:SeriesCPreferredStockMember 2024-01-08 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2024-02-27 2024-03-01 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2024-03-01 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2025-01-01 2025-12-31 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2024-01-01 2024-12-31 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2025-12-31 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2024-12-31 0001290658 ITOX:SeriesDConvertiblePreferredStockMember 2025-03-17 0001290658 us-gaap:SeriesDPreferredStockMember 2025-03-17 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-03-20 2025-03-21 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-03-21 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2025-04-09 2025-04-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2025-04-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-05-13 2025-05-14 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-05-09 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-05-13 2025-05-14 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-05-09 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2025-10-29 2025-10-30 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2025-10-30 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2025-12-01 2025-12-02 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2025-12-02 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2025-01-01 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2025-12-31 0001290658 us-gaap:SeriesFPreferredStockMember 2025-10-30 0001290658 ITOX:EmmonsDEAMember 2025-10-29 2025-10-30 0001290658 ITOX:EmmonsDEAMember us-gaap:SeriesEPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:EmmonsDEAMember us-gaap:SeriesAPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:EmmonsDEAMember us-gaap:SeriesEPreferredStockMember 2025-12-31 0001290658 ITOX:MittaDEAMember 2025-10-29 2025-10-30 0001290658 ITOX:MittaDEAMember us-gaap:SeriesEPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:MittaDEAMember us-gaap:SeriesAPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:MittaDEAMember us-gaap:SeriesEPreferredStockMember 2025-12-31 0001290658 ITOX:McNemarDEAMember 2025-10-29 2025-10-30 0001290658 ITOX:McNemarDEAMember us-gaap:SeriesEPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:McNemarDEAMember us-gaap:SeriesAPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:McNemarDEAMember us-gaap:SeriesEPreferredStockMember 2025-12-31 0001290658 ITOX:SeniorSecuredHoldersMember 2025-10-29 2025-10-30 0001290658 ITOX:SeniorSecuredHoldersMember us-gaap:SeriesEPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:SeniorSecuredHoldersMember us-gaap:SeriesEPreferredStockMember 2025-12-31 0001290658 ITOX:SeriesBConvertiblePreferredStockMember 2025-12-31 0001290658 ITOX:SeriesBConvertiblePreferredStockMember 2024-12-31 0001290658 ITOX:SeriesCConvertiblePreferredStockMember 2025-12-31 0001290658 ITOX:SeriesCConvertiblePreferredStockMember 2024-12-31 0001290658 ITOX:SeriesDConvertiblePreferredStockMember 2025-12-31 0001290658 ITOX:SeriesDConvertiblePreferredStockMember 2024-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2023-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2024-12-31 0001290658 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001290658 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001290658 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001290658 us-gaap:FairValueInputsLevel1Member 2024-01-01 2024-12-31 0001290658 us-gaap:FairValueInputsLevel2Member 2024-01-01 2024-12-31 0001290658 us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-12-31 0001290658 us-gaap:FairValueInputsLevel1Member 2024-12-31 0001290658 us-gaap:FairValueInputsLevel2Member 2024-12-31 0001290658 us-gaap:FairValueInputsLevel3Member 2024-12-31 0001290658 us-gaap:FairValueInputsLevel1Member 2025-01-01 2025-12-31 0001290658 us-gaap:FairValueInputsLevel2Member 2025-01-01 2025-12-31 0001290658 us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-12-31 0001290658 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001290658 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001290658 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001290658 2023-01-01 2023-12-31 0001290658 us-gaap:DomesticCountryMember 2025-01-01 2025-12-31 0001290658 us-gaap:DomesticCountryMember 2024-01-01 2024-12-31 0001290658 us-gaap:StateAndLocalJurisdictionMember 2025-01-01 2025-12-31 0001290658 us-gaap:StateAndLocalJurisdictionMember 2024-01-01 2024-12-31 0001290658 ITOX:IncomeTaxReconciliationMember 2025-01-01 2025-12-31 0001290658 ITOX:IncomeTaxReconciliationMember 2024-01-01 2024-12-31 iso4217:USD shares iso4217:USD shares pure ITOX:Integer false 2025 FY 0001290658

10-K true 2025-12-31 --12-31 false 000-50773 IIOT-OXYS, INC. NV 81-3485426 705 Cambridge Street Cambridge MA 02141 401 307-3092 Common Stock, Par Value $0.001 No No Yes Yes Non-accelerated Filer true false false false false 339789 586385063 Risk Management and Strategy <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20250101__20251231_z6FMcg2bx4ic">Our website is monitored by a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20250101__20251231_zJpwy12E5A52">third party to check if our website is secure. We are prepared to inform all parties necessary if any breach of cyber-security were to happen. We have never had this problem and so we have never had to inform consultants, auditors, or other third parties. We have never had a breach of cyber-security at any point in our past. The risk to us of cybersecurity threats is in data storage of customer questions and emails. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20250101__20251231_z9GbSjFwcnL">A breach of customers’ data <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250101__20251231_zCQoCyTFSGFl">could negatively materially affect our public trust and could result in loss of customers and revenue. true true A breach of customers’ data <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbT_c20250101__20251231_zCQoCyTFSGFl">could negatively materially affect our public trust and could result in loss of customers and revenue. true Governance <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_ziIvTwM5YjD9">Our board of directors has no specific processes for monitoring cybersecurity within the Company. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90B_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250101__20251231_zxH4vHS3egk6">There is no subcommittee specifically for monitoring cybersecurity in the company. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20250101__20251231_z15cjjdRQcGg">Our management monitors our websites and online accounts frequently to manage risks associated with cyber-security risks. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_c20250101__20251231_ztglJCOHvbk7">Our management communicates with our board on matters of cybersecurity but, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbF_c20250101__20251231_zrbjJBLqmivb">has not had to inform them of any breaches thus far. Our board of directors has no specific processes for monitoring cybersecurity within the Company. There is no subcommittee specifically for monitoring cybersecurity in the company. Our management monitors our websites and online accounts frequently to manage risks associated with cyber-security risks. Our management communicates with our board on matters of cybersecurity but, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_dbF_c20250101__20251231_zrbjJBLqmivb">has not had to inform them of any breaches thus far. false false false false false Due to limited resources and the small number of our management, we do not have an insider trading policy. false true Fruci & Associates II 5525 Spokane, Washington

26342

23593

2139

26342

25732

149449

26342

175181

196794

322473

1141681

693914

31425

13942

138942

0 18638

538981

951532

758787

2335374

2503160

255000

1000 1000

2336374

2759160

600

0.001

1200 1200

583

699600

694800

699600

694800

5000

0.001

1200 1200

68400

259

0.001

1200 1200

210

252200

252000

0.001

10000000

100

25845

1207

0.001

10000000000

586285063

555015293

586286

555016

8733193

7306031

-12649512

-11208252

-3330032

-3347179

26342

175181

2500

2125

375

49500

49636

99949

163200

200000

153857

147991

66285

30647

532791

428274

40258

-111523

-32203

78884

282952

174541

70958

34228

-125055

-251836

-657846

-679735

-657846

-679735

783414

84920

-1441260

-764655

-0.00

565137893

545780320

25845

470015293

470016

7350291

-10443597

-2623264

85000000

85000

-38000

47000

-6260

84920

-679735

25845

555015293

555016

7306031

-11208252

-3347179

-25845 -26 26 100 1207 1 1448861 1448862 11000000 11000 400 11400

300000

300

360

-12200

19969770 19970 -9985 9985

783414

-657846

100

1207

586285063

586286

8733193

-12649512

-3330032

-1441260

-764655

49500

49636

99949

11760

46800

40258

-111523

-0

-5460

-2139

-166

-125679

118276

816103

159776

233003

111612

-18638 3413

171530

158402

-195051

-46391

75600

210000

12200

6260

197800

69340

2749

22949

23593

644

26342

23593

0 115825 9985 0 1448861 0

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Unless otherwise indicated, any reference to “the Company”, “we”, “us”, or “its” refers to IIOT-OXYS, Inc., a Nevada corporation, and as applicable to its wholly owned subsidiaries, OXYS Corporation, a Nevada corporation, and HereLab, Inc., a Delaware corporation. IIOT-OXYS, Inc., incorporated in Nevada on July 6, 2017, (the “Company”) was established for the purpose of designing, building, testing, and selling Edge Computing Systems for the Industrial Internet. The Company is currently devoting substantially all its efforts in identifying, developing and marketing engineered products, software and services for applications in the Industrial Internet which involves collecting and processing data collected from a wide variety of industrial systems and machines. On October 30, 2025, the Company had a change of control in management, and the Company and its debtholders mutually agreed to convert convertible promissory notes due, and compensation due to officers in exchange for issuance of Series E Preferred Stock in full settlement of all balances due (Note 4, Note 5, Note 7 and Note 8). Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company. The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Certain prior year balances are reclassified to conform with current year balances for presentation purposes, resulting in no change in assets, liabilities and stockholders’ equity. Principles of Consolidation The consolidated financial statements for the years ended December 31, 2025 and 2024, respectively, include the accounts of Company, and its wholly-owned subsidiaries OXYS Corporation and HereLab, Inc. HereLab, Inc. currently is a non-operating entity and has no significant transactions. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related parties. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Going Concern The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has suffered continuing operating losses, has a working capital deficit of $2,309,032, net loss incurred for the year ended December 31, 2025 of $1,441,260, cash used in operating activities of $195,051, and has an accumulated deficit of $12,649,512 as of December 31, 2025. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying condensed financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management believes that the Company will be able to achieve a satisfactory level of liquidity to meet the Company’s obligations for the next twelve months by generating cash through additional borrowings and/or sale of equity securities, as needed. However, there can be no assurance that the Company will be able to generate sufficient liquidity to maintain its operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company. The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Certain prior year balances are reclassified to conform with current year balances for presentation purposes, resulting in no change in assets, liabilities and stockholders’ equity.

Principles of Consolidation The consolidated financial statements for the years ended December 31, 2025 and 2024, respectively, include the accounts of Company, and its wholly-owned subsidiaries OXYS Corporation and HereLab, Inc. HereLab, Inc. currently is a non-operating entity and has no significant transactions. All significant intercompany balances and transactions have been eliminated.

Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related parties. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Going Concern The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has suffered continuing operating losses, has a working capital deficit of $2,309,032, net loss incurred for the year ended December 31, 2025 of $1,441,260, cash used in operating activities of $195,051, and has an accumulated deficit of $12,649,512 as of December 31, 2025. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying condensed financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management believes that the Company will be able to achieve a satisfactory level of liquidity to meet the Company’s obligations for the next twelve months by generating cash through additional borrowings and/or sale of equity securities, as needed. However, there can be no assurance that the Company will be able to generate sufficient liquidity to maintain its operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. -2309032

-1441260

-195051

-12649512

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The following summary of the significant accounting policies of the Company is presented to assist in the understanding of the Company’s financial statements. These accounting policies conform to the generally accepted accounting principles (the “GAAP”) in all material respects and have been consistently applied in preparing the accompanying consolidated financial statements. Cash and Cash Equivalents The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. The Company reported a cash balance of $26,342 and $23,593 as of December 31, 2025 and 2024, respectively. Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. The Company determines the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an ageing of accounts and follows the guidelines and processes of measuring both current and expected future credit losses. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The Company adopted and implemented Accounting Standards Codification (“ASC”) Topic 326 Financial Instruments – Credit Losses during 2023 which has no impact on the financial statements as of December 31, 2025 and 2024, respectively. There was no allowance for doubtful accounts as of December 31, 2025 and 2024, respectively. Long-Lived Assets The Company regularly reviews the carrying value and estimated lives of its long-lived assets to determine whether indicators of impairment may exist that warrant adjustments to the carrying value or estimated useful lives. The determinants used for this evaluation include management’s estimate of the asset’s ability to generate positive income from operations and positive cash flow in future periods as well as the strategic significance of the assets to the Company’s business objectives. Definite-lived intangible assets are amortized on a straight-line basis over the estimated periods benefited and are reviewed when appropriate for possible impairment. Basic and Diluted Earnings (Loss) Per Common Share The Company computes earnings (loss) per share in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”), ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. Revenue Recognition The Company recognizes revenue when the products are delivered to the customer or services are performed in accordance with the contractual terms of the contract with its customer. The Company recognizes revenue in accordance with ASC Topic No. 606, Revenue from Contracts with Customers which was adopted on January 1, 2018. The Company recognizes revenue based on the following criteria of ASC 606: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">Identification of a contract or contracts with a customer.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Identification of the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Determination of contract price.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Allocation of transaction price to the performance obligation.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Recognition of revenue when, or as, performance obligation is satisfied.</td></tr> </table> The Company used a practical expedient available under ASC 606-10-65-1(f)4 that permits it to consider the aggregate effect of all contract modifications that occurred before the beginning of the earliest period presented when identifying satisfied and unsatisfied performance obligations, transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations. The Company has elected to treat shipping and handling activities as the cost of sales. Additionally, the Company has elected to record revenue net of sales and other similar taxes. Concentration of Credit Risk Financial instruments that potentially expose the Company to concentrations of risk consist primarily of cash and cash equivalents which are generally not collateralized. The Company’s policy is to place its cash and cash equivalents with high quality financial institutions, in order to limit the amount of credit exposure. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (FDIC), up to $250,000. At December 31, 2025 and 2024, the Company had no amounts in excess of the FDIC insurance limit. Fair Value of Financial Instruments and Fair Value Measurements ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company recorded derivative liabilities as Level 3 to measure the fair value of the change in derivative liabilities. The Company’s consolidated financial instruments consist principally of cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities, notes payable and related parties payable. The Company believes that the recorded values of all the financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. On October 30, 2025, the Company had a change of control in management and mutually agreed to cancel the three equity incentive plans (a) 952,212 unissued shares of common stock pursuant to the 2017 Plan, (b) 1,470,000 unissued shares of common stock pursuant to the 2019 Plan, and (c) 5,700,000 unissued shares of common stock pursuant to the 2022 Plan. At December 31, 2025, 0 shares of common stock remain unissued pursuant to the 2017 Plan, 2019 Plan and 2022 Plan. All three equity incentive plans were terminated effective December 31, 2025. Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provide that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions.” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Convertible Debt and Convertible Preferred Stock When the Company issues convertible debt or convertible preferred stock, it first evaluates the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480, Distinguishing Liabilities from Equity, and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a standalone instrument, meets the definition of an “embedded derivative” in ASC 815, Derivatives and Hedging. Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the consolidated balance sheet at fair value, with any changes in its fair value recognized currently in the consolidated statements of operations. Effective January 1, 2022, the Company early adopted ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” using the modified retrospective method of adoption. ASU 2020-06 simplifies the accounting for convertible instruments by removing certain separation models in Subtopic 470- 20, Debt—Debt with Conversion and Other Options, for convertible instruments. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost as long as no other features require bifurcation and recognition as derivatives. By removing those separation models, the interest rate of convertible debt instruments typically will be closer to the coupon interest rate when applying the guidance in Topic 835, Interest. The Company accounts for its Convertible Notes as single liabilities measured at amortized cost. As a result, the adoption of the guidance had a material impact on the consolidated financial statements and accompanying notes, resulting in adjustments of $371,125, $313,976 and $57,149 to the opening balance of additional paid-in capital, retained earnings, and long-term debt, respectively, as of January 1, 2022. The Company has updated its debt note (Note 5) with additional and modified disclosures as required by the standard upon adoption Segment Information The Company’s Chief Executive Officer (“CEO”) is our chief operating decision maker (“CODM”) and evaluates performance and makes operating decisions about allocating resources based on financial data presented on a consolidated basis. The Company is devoting all its efforts to identifying technologies in developing and marketing engineered products, software and services for applications in the Industrial Internet, which involves collecting and processing data collected from a wide variety of industrial systems and machines. The Company’s CODM has determined that it operates as a single reportable segment. Recent Accounting Pronouncements In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 720): Improvements to Income Tax Disclosures (“ASU 2023-09”), which prescribes standard categories for the components of the effective tax rate reconciliation and requires disclosure of additional information for reconciling items meeting certain quantitative thresholds, requires disclosure of disaggregated income taxes paid, and modifies certain other income tax-related disclosures. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. The Company adopted the ASU 2023-09 as of January 1, 2024 and it did not have an impact of the adoption of ASU 2023-09 on its consolidated financial statements. In November 2024, the FASB issued ASU 2024-03 – Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40); Disaggregation of Income Statement Expenses. ASU 2024-03 is effective for public business entities for annual periods beginning after December 15, 2026. The Company is currently evaluating the impact, if any, that the updated standard will have on the consolidated financial statements.

Cash and Cash Equivalents The Company considers all highly liquid instruments with a maturity of three months or less at the time of issuance to be cash equivalents. The Company reported a cash balance of $26,342 and $23,593 as of December 31, 2025 and 2024, respectively.

26342

23593

Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts. The Company determines the allowance for doubtful accounts by identifying potential troubled accounts and by using historical experience and future expectations applied to an ageing of accounts and follows the guidelines and processes of measuring both current and expected future credit losses. Trade accounts receivable are written off when deemed uncollectible. Recoveries of trade accounts receivable previously written off are recorded as income when received. The Company adopted and implemented Accounting Standards Codification (“ASC”) Topic 326 Financial Instruments – Credit Losses during 2023 which has no impact on the financial statements as of December 31, 2025 and 2024, respectively. There was no allowance for doubtful accounts as of December 31, 2025 and 2024, respectively.

Long-Lived Assets The Company regularly reviews the carrying value and estimated lives of its long-lived assets to determine whether indicators of impairment may exist that warrant adjustments to the carrying value or estimated useful lives. The determinants used for this evaluation include management’s estimate of the asset’s ability to generate positive income from operations and positive cash flow in future periods as well as the strategic significance of the assets to the Company’s business objectives. Definite-lived intangible assets are amortized on a straight-line basis over the estimated periods benefited and are reviewed when appropriate for possible impairment.

Basic and Diluted Earnings (Loss) Per Common Share The Company computes earnings (loss) per share in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”), ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

Revenue Recognition The Company recognizes revenue when the products are delivered to the customer or services are performed in accordance with the contractual terms of the contract with its customer. The Company recognizes revenue in accordance with ASC Topic No. 606, Revenue from Contracts with Customers which was adopted on January 1, 2018. The Company recognizes revenue based on the following criteria of ASC 606: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">Identification of a contract or contracts with a customer.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Identification of the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Determination of contract price.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Allocation of transaction price to the performance obligation.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Recognition of revenue when, or as, performance obligation is satisfied.</td></tr> </table> The Company used a practical expedient available under ASC 606-10-65-1(f)4 that permits it to consider the aggregate effect of all contract modifications that occurred before the beginning of the earliest period presented when identifying satisfied and unsatisfied performance obligations, transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations. The Company has elected to treat shipping and handling activities as the cost of sales. Additionally, the Company has elected to record revenue net of sales and other similar taxes.

Concentration of Credit Risk Financial instruments that potentially expose the Company to concentrations of risk consist primarily of cash and cash equivalents which are generally not collateralized. The Company’s policy is to place its cash and cash equivalents with high quality financial institutions, in order to limit the amount of credit exposure. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (FDIC), up to $250,000. At December 31, 2025 and 2024, the Company had no amounts in excess of the FDIC insurance limit.

Fair Value of Financial Instruments and Fair Value Measurements ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company recorded derivative liabilities as Level 3 to measure the fair value of the change in derivative liabilities. The Company’s consolidated financial instruments consist principally of cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities, notes payable and related parties payable. The Company believes that the recorded values of all the financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. On October 30, 2025, the Company had a change of control in management and mutually agreed to cancel the three equity incentive plans (a) 952,212 unissued shares of common stock pursuant to the 2017 Plan, (b) 1,470,000 unissued shares of common stock pursuant to the 2019 Plan, and (c) 5,700,000 unissued shares of common stock pursuant to the 2022 Plan. At December 31, 2025, 0 shares of common stock remain unissued pursuant to the 2017 Plan, 2019 Plan and 2022 Plan. All three equity incentive plans were terminated effective December 31, 2025.

Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provide that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions.” When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

Convertible Debt and Convertible Preferred Stock When the Company issues convertible debt or convertible preferred stock, it first evaluates the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480, Distinguishing Liabilities from Equity, and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a standalone instrument, meets the definition of an “embedded derivative” in ASC 815, Derivatives and Hedging. Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the consolidated balance sheet at fair value, with any changes in its fair value recognized currently in the consolidated statements of operations. Effective January 1, 2022, the Company early adopted ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” using the modified retrospective method of adoption. ASU 2020-06 simplifies the accounting for convertible instruments by removing certain separation models in Subtopic 470- 20, Debt—Debt with Conversion and Other Options, for convertible instruments. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost as long as no other features require bifurcation and recognition as derivatives. By removing those separation models, the interest rate of convertible debt instruments typically will be closer to the coupon interest rate when applying the guidance in Topic 835, Interest. The Company accounts for its Convertible Notes as single liabilities measured at amortized cost. As a result, the adoption of the guidance had a material impact on the consolidated financial statements and accompanying notes, resulting in adjustments of $371,125, $313,976 and $57,149 to the opening balance of additional paid-in capital, retained earnings, and long-term debt, respectively, as of January 1, 2022. The Company has updated its debt note (Note 5) with additional and modified disclosures as required by the standard upon adoption

Segment Information The Company’s Chief Executive Officer (“CEO”) is our chief operating decision maker (“CODM”) and evaluates performance and makes operating decisions about allocating resources based on financial data presented on a consolidated basis. The Company is devoting all its efforts to identifying technologies in developing and marketing engineered products, software and services for applications in the Industrial Internet, which involves collecting and processing data collected from a wide variety of industrial systems and machines. The Company’s CODM has determined that it operates as a single reportable segment.

Recent Accounting Pronouncements In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 720): Improvements to Income Tax Disclosures (“ASU 2023-09”), which prescribes standard categories for the components of the effective tax rate reconciliation and requires disclosure of additional information for reconciling items meeting certain quantitative thresholds, requires disclosure of disaggregated income taxes paid, and modifies certain other income tax-related disclosures. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 and allows for adoption on a prospective basis, with a retrospective option. The Company adopted the ASU 2023-09 as of January 1, 2024 and it did not have an impact of the adoption of ASU 2023-09 on its consolidated financial statements. In November 2024, the FASB issued ASU 2024-03 – Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40); Disaggregation of Income Statement Expenses. ASU 2024-03 is effective for public business entities for annual periods beginning after December 15, 2026. The Company is currently evaluating the impact, if any, that the updated standard will have on the consolidated financial statements.

NOTE 3 – INTANGIBLE ASSETS The Company’s intangible assets comprise of intellectual property revolving around their field tests, sensor integrations, and board designs. Intangible assets, net of amortization, amounted to $0 and $149,449 as of December 31, 2025 and 2024, respectively. <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_ziMlvJr2Uw79" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of intangible assets</td><td> </td> <td colspan="2" id="xdx_497_20251231_zcstWKbyjDwc" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49D_20241231_zvKe1he0BcGc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_maFLIANzWN2_z6gpl4ly6Qtb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Intangible Assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">495,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Write-down of intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(99,949</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_d0_c20240101__20241231_zPVHv0wDz1of" style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzWN2_zCWNIIDN6amg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(395,051</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(345,551</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_d0_mtFLIANzWN2_zfxjWxNt5q2a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible Assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">149,449</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company determined that its intangible assets were impaired totaling $99,949 and $0 for the years ended December 31, 2025 and 2024, respectively. Amortizable intangible assets are amortized using the straight-line method over their estimated useful lives of ten years. The amortization expense of finite-lived intangibles was $49,500 and $49,636 for the years ended December 31, 2025 and 2024, respectively.

149449

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_ziMlvJr2Uw79" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom"> <td>Schedule of intangible assets</td><td> </td> <td colspan="2" id="xdx_497_20251231_zcstWKbyjDwc" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49D_20241231_zvKe1he0BcGc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_maFLIANzWN2_z6gpl4ly6Qtb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Intangible Assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">495,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Write-down of intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(99,949</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_d0_c20240101__20241231_zPVHv0wDz1of" style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzWN2_zCWNIIDN6amg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(395,051</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(345,551</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_d0_mtFLIANzWN2_zfxjWxNt5q2a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible Assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">149,449</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

495000

99949

395051

345551

149449

99949

49500

49636

NOTE 4 – COMMITMENTS AND CONTINGENCIES In prior years, the Company entered into consulting agreements with one director, three executive officers, and one engineer of the Company, which included commitments to issue shares of the Company’s common stock from the Company’s 2017 Stock Incentive Plan and 2019 Stock Incentive Plans. The authorized shares pursuant to the 2017 Stock Incentive Plan (“2017 Plan”) were <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zV72K5jhA8Q7" title="Shares authorized under plan">4,500,000 shares, and per 2019 Stock Incentive Plan (“2019 Plan”) were <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zewwbh0lQ80h">5,000,000 shares. The consulting agreements with two consultants have been terminated and shares have been issued in conjunction with the related separation agreements. The vested shares related to the three advisors and the executive officers have not yet been issued in full and therefore remain a liability. According to the terms of the agreements, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zCJBuZqPScq4" title="Stock vested, shares"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zqlvJbxrAxf4" title="Stock vested, shares">3,547,788 shares were vested and issued per the Company’s 2017 Plan as of December 31, 2025 and 2024, and <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zS9Xjrpdbcqf" title="Stock vested, shares"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zviLTXbFAdVh" title="Stock vested, shares">3,530,000 shares were vested and issued per the Company’s 2019 Plan as of December 31, 2025 and 2024, respectively. In the event that a consulting agreement is terminated by either party pursuant to the terms of the agreement, all unvested shares which have been earned shall vest on a pro-rata basis as of the effective date of the termination of the agreement and all unearned, unvested shares shall be terminated. The value of the shares was assigned to a fair market value on the effective date of the agreement and the pro-rata number of shares earned was calculated and amortized at the end of each reporting period. On March 18, 2022, the Company adopted 2022 Stock Incentive Plan (“2022 Plan”) and reserved <span id="xdx_90D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20220318__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z4OWIcooQ0m2" title="Common stock reserved for issuance">20,000,000 shares of common stock for issuance to incentivize its management team. Pursuant to the terms of the 2022 Plan, <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_ze4pYHAK1Oo" title="Stock vested, shares">14,300,000 shares of common stock were vested and <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zujOk6Wqng42" title="Stock issued, shares">14,200,000 shares and <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zmquKlmuJUd5" title="Stock issued, shares">3,100,000 were issued as of December 31, 2025 and 2024, respectively. 100,000 shares vested remained to be issued to an advisor pursuant to 2022 Plan as of December 31, 2025. On October 30, 2025, the Company had a change in control of management and all unvested shares pursuant to the 2017 Plan, 2019 Plan, and 2022 Plan were forfeited and cancelled. The Board of Directors subsequently terminated each of the 2017 Plan, the 2019 Plan, and the 2022 Plan effective December 31, 2025. As of December 31, 2025, there were no unvested shares remaining under any of the Plans. Employment Agreement – CEO On June 2, 2022, the Board approved an Employment Agreement with the CEO dated effective April 1, 2022 whereby, the CEO will receive an annual salary of $100,000 which accrues unless converted into shares of common stock of the Company at a stipulated conversion rate. If the Company reaches $1,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $150,000 commencing the following month. If the Company reaches $5,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $200,000 commencing the following month. The Company awarded the CEO an aggregate of 7,000,000 shares of the Company’s common stock under the 2022 Plan, which will vest (i) 1,500,000 shares on April 1, 2023, (ii) 2,500,000 shares on April 1, 2024, and (iii) 3,000,000 shares on April 1, 2025. The shares are valued at 90% of the average market price of the shares of 30 trading days at the end of each quarter. The Company recorded $353,939 and $279,352 in salaries payable to the CEO as of October 30, 2025 and December 31, 2024, respectively. On October 30, 2025, the Company had a change in control of the management, and the Employment Agreement of the CEO was terminated. The Company and the CEO mutually agreed to settle the past due salary payable of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--NatureOfExpenseAxis__custom--SalaryPayableMember_z1bTh1YYU0oa" title="Debt converted, amount converted">353,939, and reimbursable expenses and incentives of $<span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--NatureOfExpenseAxis__custom--ReimbursableExpensesAndIncentivesMember_zsUP53bGZON3" title="Debt converted, amount converted">33,303, in exchange for <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8alU3IzRxo5" title="Debt converted, shares issued">269 shares of Series E Preferred Stock (Note 8). Employment Agreement – COO/Interim CFO On June 2, 2022, the Board approved an Employment Agreement with the COO/Interim CFO dated effective April 1, 2022, whereby, the officer will receive an annual salary of $100,000 which accrues unless converted into shares of common stock of the Company at a stipulated conversion rate. If the Company reaches $1,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $150,000 commencing the following month. If the Company reaches $5,000,000 in cumulative sales over a 12-month period, the annual salary will increase to $200,000 commencing the following month. The Company awarded the COO/Interim CFO an aggregate of 7,000,000 shares of the Company common stock under the 2022 Plan, which will vest (i) 1,500,000 shares on April 1, 2023, (ii) <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20220602__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember__us-gaap--AwardDateAxis__custom--April12024Member_zxYXOcXs0SKd" title="Stock vested, shares">2,500,000 shares on April 1, 2024, and (iii) 3,000,000 shares on April 1, 2025. The shares are valued at 90% of the average market price of the shares of 30 trading days at the end of each quarter. The Company recorded $309,603 and $263,041 in salaries payable to the COO/Interim CFO as of October 30, 2025 and December 31, 2024, respectively. On October 30, 2025, the Company had a change in control of the management, and the Employment Agreement of the CEO was terminated. The Company and the COO/Interim CFO mutually agreed to settle the past due salary payable of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember__us-gaap--NatureOfExpenseAxis__custom--SalaryPayableMember_zf4WxjDZ1zj2" title="Debt converted, amount converted">309,603, and reimbursable expenses of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember__us-gaap--NatureOfExpenseAxis__custom--ReimbursableExpensesAndIncentivesMember_zTDqgtIFFPTa" title="Debt converted, amount converted">13,666, in exchange for <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20250101__20251231__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zRkFYYHygnt" title="Debt converted, shares issued">269 shares of Series E Preferred Stock (Note 8).

4500000

5000000

3547788

3530000

20000000

14300000

14200000

3100000

353939

279352

353939

33303

269

2500000

309603

263041

309603

13666

269

NOTE 5 – CONVERTIBLE NOTES PAYABLE The following table summarizes the outstanding balance of convertible notes payable, interest and conversion rates as of December 31, 2025 and 2024, respectively. <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_z8kdvWeGM4I9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td>Schedule of outstanding balance of convertible notes payable</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2024</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; width: 3%; font-weight: bold; text-align: center">A.</td><td style="width: 2%"> </td> <td style="width: 61%; text-align: justify">Convertible note payable to an investor with interest at 12% per annum, convertible at any time into shares of common stock at the lowest VWAP or $0.001 per share. The note is secured by substantially all the assets of the Company.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableAMember_z9ltIarcLzCl" style="width: 13%; text-align: right" title="Convertible note payable, gross">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableAMember_zPzC3VhRWOv9" style="width: 13%; text-align: right" title="Convertible note payable, gross">205,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; font-weight: bold; text-align: center">D.</td><td> </td> <td style="text-align: justify">Convertible note payable to an investor with interest at 12% per annum, convertible at any time into shares of common stock at the lowest VWAP or $0.001 per share. The note is secured by substantially all the assets of the Company.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableDMember_zxXcee2Pc3Kk" style="text-align: right" title="Convertible note payable, gross">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableDMember_zw5dazyFRqL2" style="text-align: right" title="Convertible note payable, gross">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; font-weight: bold; text-align: center">E.</td><td> </td> <td style="text-align: justify">Convertible note payable to a related party with interest at 12% per annum, convertible at any time into shares of common stock at $0.0006 per share. Interest is payable. The note is secured by substantially all the assets of the Company.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableEMember_z63TFbowYSVf" style="text-align: right" title="Convertible note payable, gross">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableEMember_zTkZicQfLaaf" style="text-align: right" title="Convertible note payable, gross">125,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; padding-bottom: 1pt; font-weight: bold; text-align: center">G.</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: justify; padding-bottom: 1pt">Convertible note payable to an investor with interest at 10% per annum, convertible at any time into shares of common stock at $0.0006 per share. Note was issued as payment for future fees to be incurred under the related Equity Financing Agreement. Principal and interest due on maturity on April 29, 2026. The note is secured by substantially all the assets of the Company.</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_zRp3ok6bH0ej" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible note payable, gross">13,942</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_z4hp8Ti2cgfl" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible note payable, gross">13,942</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231_zvKYBHN8XM5c" style="text-align: right" title="Convertible notes payable">13,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231_ztJNbFTJlT0e" style="text-align: right" title="Convertible notes payable">393,942</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20251231_zwhEnhFY3oQd" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(13,942</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20241231_zp53uvsUNFxl" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(138,942</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_c20251231_zzUBIYsozmr" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ConvertibleLongTermNotesPayable_pp0p0_c20241231_zWpil71krvaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">255,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> A. January 18, 2018 Convertible Note and Warrants (“Note A”) On March 14, 2022, the noteholder of Note A agreed to extend the maturity date of March 1, 2022 of the Senior Secured Convertible Promissory Note to March 1, 2023, in exchange for the reduction of the conversion price to $0.008 per share, and all prior Events of Default (as defined in the Note A) including penalties were waived, and all future Events of Default (as defined in the Note A) pertaining to the future payment of interest were waived through maturity. On July 21, 2023, the noteholder of Note A agreed to extend the maturity date to March 1, 2024 and then Note A was automatically extended for one-year term to March 1, 2026 unless written notice of objection was provided by the noteholder. The Note A is convertible into shares of common stock at the lowest VWAP or $0.001 per share during the look back period of 10 days prior to the conversion date, provided: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">Upon request of the noteholder of Note A, the Company shall issue twenty thousand dollars ($20,000) worth of common shares (the “1st Incentive Shares) and the price per 1st Incentive Share shall be the Volume-Weighted Average Price (VWAP) per common share of the Company (subject to adjustments) for the previous ten trading days.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">The Company shall use its best efforts to file a registration statement registering the resales of the 1st Incentive Shares within 45 calendar days from the date hereof. The Company shall use is best efforts to have the registration statement declared “effective” within sixty (60) calendar days from its filing. The Company shall use its best efforts to have a registration statement registering the resales of the 1st Incentive Shares remain effective until such time that the noteholder of Note A no longer holds any such 1st Incentive Shares. </td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Upon full conversion of the Note A and Note D, the Company shall issue to the holder of Note A fifty thousand dollars ($50,000) worth of common shares (the “2nd Incentive Shares”) and the price per 2nd Incentive Share shall be the VWAP per common share of the Company (subject to adjustments) for the previous ten (10) Trading Days.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">The Company shall use its best efforts to file a registration statement registering the resales of the 2nd Incentive Shares within forty-five (45) calendar days from the date of issuance. The Company shall use is best efforts to have the registration statement declared “effective” within sixty (60) calendar days from its filing. The Company shall use its best efforts to have a registration statement registering the resales of the 2nd Incentive Shares remain effective until such time that the noteholder of Note A no longer holds any such 2nd Incentive Shares.</td></tr> </table> On October 30, 2025, the Company had a change of control in management, and mutually agreed with the holder of Note A to convert the principal balance of Note A of $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableAMember_zlDcppfWTCY9" title="Debt converted, amount converted">205,000 and accrued interest of $<span id="xdx_900_ecustom--DebtConversionConvertedInterestAmount1_pp0p0_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableAMember_zEyyz52NRSUi" title="Debt converted, interest converted">229,511 as of date, in exchange for issuance of <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableAMember_zydowlDTL4ob" title="Debt converted, shares issued">407 shares of Series E Preferred Stock in full settlement of all balances due to Note A holder (Note 8). The Company recorded interest expense of $20,376 and $24,667 for the years ended December 31, 2025 and 2024, respective. Accrued interest payable on Note A was $0 and $209,135 as of December 31, 2025 and 2024, respectively. D. March 2019 Convertible Note and Warrants (“Note D”) On March 14, 2022, the noteholder of Note D agreed to extend the maturity date of March 1, 2022 of the Senior Secured Convertible Promissory Note to March 1, 2023, in exchange for the reduction of the conversion price to $0.008 per share, and all prior Events of Default (as defined in the Note D) including penalties were waived, and all future Events of Default (as defined in the Note D) pertaining to the future payment of interest were waived through maturity. On July 21, 2023, the noteholder of Note D agreed to extend the maturity date to March 1, 2024 and then Note D was automatically extended for one-year term to March 1, 2026 unless written notice of objection was provided by the noteholder. The Note D is convertible into shares of common stock at the lowest VWAP or $0.001 per share during the look back period (see “Note A” above). On October 30, 2025, the Company had a change of control in management, and mutually agreed with the holder of Note D to convert the principal balance of Note D of $<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableDMember_z5F2XuHN5zi8" title="Debt converted, amount converted">50,000 and accrued interest of $<span id="xdx_909_ecustom--DebtConversionConvertedInterestAmount1_pp0p0_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableDMember_zn1zXWyy0sf8" title="Debt converted, interest converted">37,684 as of date, in exchange for issuance of <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableDMember_zMpPaGJPDhXe" title="Debt converted, shares issued">82 shares of Series E Preferred Stock in full settlement of all balances due to Note D holder (Note 8). The Company recorded interest expense of $4,970 and $6,016 for the years ended December 31, 2025 and 2024, respective. Accrued interest payable on Note D was $0 and $32,714 as of December 31, 2025 and 2024, respectively. E. August 2019 Convertible Note and Warrants (“Note E”) On August 6, 2025, the noteholder of Note E agreed to extend the maturity date of the Senior Secured Convertible Promissory Note to February 2, 2026 for no additional consideration. All other terms and conditions of the Note E remained the same. On October 30, 2025, the Company had a change of control in management, and mutually agreed with the holder of Note E to convert the principal balance of Note E of $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableEMember_zErGi4A7sOs8" title="Debt converted, amount converted">125,000 and accrued interest of $<span id="xdx_902_ecustom--DebtConversionConvertedInterestAmount1_pp0p0_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableEMember_zEmRQs3SX6th" title="Debt converted, interest converted">91,156 as of date, in exchange for issuance of <span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableEMember_zrygA53b70t4" title="Debt converted, shares issued">180 shares of Series E Preferred Stock in full settlement of all balances due to Note E holder (Note 8). The Company recorded interest expense of $12,425 and $15,941 on Note E for the years ended December 31, 2025 and 2024, respectively. Accrued interest payable on Note E was $0 and 78,731 as of December 31, 2025 and 2024, respectively. G . July 2020 Equity Financing Arrangement (“Note G”) On May 14, 2025, the noteholder of Note G agreed to extend the maturity date of the Secured Convertible Promissory Note from April 29, 2025 to October 29, 2025, and then to April 29, 2026 (Note 9). All other terms and conditions of the Note G remained the same. During the year ended December 31, 2024, the noteholder of Note G converted principal amount of $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20240101__20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_zJLV1b42SNm6" title="Debt converted, amount converted">45,045 and accrued interest of $<span id="xdx_906_ecustom--DebtConversionConvertedInterestAmount1_pp0p0_c20240101__20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_zmkm3klYMiMc" title="Debt converted, interest converted">1,955 in exchange of <span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240101__20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_zKjzK8E5pPgh" title="Debt converted, shares issued">85,000,000 shares of common stock of the Company. The Company recorded interest expense on Note G of $1,392 and $1,123 for the years ended December 31, 2025 and 2024, respectively. Accrued interest payable on Note G was $2,517 and $1,123 as of December 31, 2025 and 2024, respectively. The principal balance payable of Note G amounted to $13,942 as of December 31, 2025 and 2024, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_z8kdvWeGM4I9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details)"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td>Schedule of outstanding balance of convertible notes payable</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2024</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; width: 3%; font-weight: bold; text-align: center">A.</td><td style="width: 2%"> </td> <td style="width: 61%; text-align: justify">Convertible note payable to an investor with interest at 12% per annum, convertible at any time into shares of common stock at the lowest VWAP or $0.001 per share. The note is secured by substantially all the assets of the Company.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableAMember_z9ltIarcLzCl" style="width: 13%; text-align: right" title="Convertible note payable, gross">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableAMember_zPzC3VhRWOv9" style="width: 13%; text-align: right" title="Convertible note payable, gross">205,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; font-weight: bold; text-align: center">D.</td><td> </td> <td style="text-align: justify">Convertible note payable to an investor with interest at 12% per annum, convertible at any time into shares of common stock at the lowest VWAP or $0.001 per share. The note is secured by substantially all the assets of the Company.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableDMember_zxXcee2Pc3Kk" style="text-align: right" title="Convertible note payable, gross">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableDMember_zw5dazyFRqL2" style="text-align: right" title="Convertible note payable, gross">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; font-weight: bold; text-align: center">E.</td><td> </td> <td style="text-align: justify">Convertible note payable to a related party with interest at 12% per annum, convertible at any time into shares of common stock at $0.0006 per share. Interest is payable. The note is secured by substantially all the assets of the Company.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_d0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableEMember_z63TFbowYSVf" style="text-align: right" title="Convertible note payable, gross">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableEMember_zTkZicQfLaaf" style="text-align: right" title="Convertible note payable, gross">125,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; padding-bottom: 1pt; font-weight: bold; text-align: center">G.</td><td style="padding-bottom: 1pt"> </td> <td style="text-align: justify; padding-bottom: 1pt">Convertible note payable to an investor with interest at 10% per annum, convertible at any time into shares of common stock at $0.0006 per share. Note was issued as payment for future fees to be incurred under the related Equity Financing Agreement. Principal and interest due on maturity on April 29, 2026. The note is secured by substantially all the assets of the Company.</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_zRp3ok6bH0ej" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible note payable, gross">13,942</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_z4hp8Ti2cgfl" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible note payable, gross">13,942</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: center"> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231_zvKYBHN8XM5c" style="text-align: right" title="Convertible notes payable">13,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20241231_ztJNbFTJlT0e" style="text-align: right" title="Convertible notes payable">393,942</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="vertical-align: top; padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20251231_zwhEnhFY3oQd" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(13,942</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20241231_zp53uvsUNFxl" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(138,942</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_c20251231_zzUBIYsozmr" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ConvertibleLongTermNotesPayable_pp0p0_c20241231_zWpil71krvaj" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">255,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

205000

50000

125000

13942

393942

13942

138942

255000

205000

229511

407

20376

24667

209135

50000

37684

4970

6016

32714

125000

91156

180

12425

15941

78731

45045

1955

85000000

1392

1123

2517

1123

13942

NOTE 6 – EARNINGS (LOSS) PER SHARE The following table sets forth the computation of basic and diluted net loss per share of common stock for the years ended December 31, 2025 and 2024, respectively: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zrOid4OJCr46" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Per share information)"> <tr style="vertical-align: bottom"> <td>Schedule of computation of basic and diluted net loss per share of common stock</td><td> </td> <td colspan="2" id="xdx_490_20250101__20251231_zxbzXWughER4" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_493_20240101__20241231_z9f6EQZCS0v9" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Net loss attributable to common stockholders (basic)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(1,441,260</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(764,655</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Shares used to compute net loss per common share, basic and diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">565,137,893</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">545,780,320</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> Basic net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company’s potentially dilutive securities, which include stock options, convertible debt, convertible preferred stock and common stock warrants have been excluded from the computation of diluted net loss per share as they would be anti-dilutive. For all periods presented, there is no difference in the number of shares used to compute basic and diluted shares outstanding due to the Company’s net loss position. The following outstanding common stock equivalents have been excluded from diluted net loss per common share for the years ended December 31, 2025 and 2024, respectively, because their inclusion would be anti-dilutive: <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zVWtYtnPNxjl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td>Schedule of anti-dilutive shares</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Potentially issuable shares related to convertible notes payable and convertible preferred stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zqPd6UufLfx3" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">1,688,880,181</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zga5VQ0uCL16" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">764,494,742</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Potentially issuable vested shares to directors, officers and advisors</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_zdrKUSCPUU0d" style="text-align: right" title="Total anti-dilutive common stock equivalents">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_zU1roIRjTuae" style="text-align: right" title="Total anti-dilutive common stock equivalents">8,300,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Potentially issuable unvested shares to directors and officers</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_z87isOxzxXv5" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_zYk8KYn0EJB5" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">6,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total anti-dilutive common stock equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zkIGbZFupkc3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">1,688,980,181</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zq7JGvbCxGd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">778,794,742</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zrOid4OJCr46" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Per share information)"> <tr style="vertical-align: bottom"> <td>Schedule of computation of basic and diluted net loss per share of common stock</td><td> </td> <td colspan="2" id="xdx_490_20250101__20251231_zxbzXWughER4" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_493_20240101__20241231_z9f6EQZCS0v9" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Net loss attributable to common stockholders (basic)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(1,441,260</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(764,655</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Shares used to compute net loss per common share, basic and diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">565,137,893</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">545,780,320</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

-1441260

-764655

565137893

545780320

-0.00

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zVWtYtnPNxjl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td>Schedule of anti-dilutive shares</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Potentially issuable shares related to convertible notes payable and convertible preferred stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zqPd6UufLfx3" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">1,688,880,181</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zga5VQ0uCL16" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">764,494,742</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Potentially issuable vested shares to directors, officers and advisors</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_zdrKUSCPUU0d" style="text-align: right" title="Total anti-dilutive common stock equivalents">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_zU1roIRjTuae" style="text-align: right" title="Total anti-dilutive common stock equivalents">8,300,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Potentially issuable unvested shares to directors and officers</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20250101__20251231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_z87isOxzxXv5" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_zYk8KYn0EJB5" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">6,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total anti-dilutive common stock equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20251231_zkIGbZFupkc3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">1,688,980,181</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20241231_zq7JGvbCxGd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">778,794,742</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1688880181

764494742

100000

8300000

6000000

1688980181

778794742

NOTE 7 – RELATED PARTIES At December 31, 2025 and December 31, 2024, respectively, the amount due to two stockholders was $1,000 relating to depositing funds for opening bank accounts for the Company. The Company leases its current office facility from these stockholders on a month-to-month basis at a monthly rent of $250 starting January 1, 2020. Rent expense totaled $3,000 for each of the years ended December 31, 2025 and 2024, respectively. On October 30, 2025, the Company issued <span id="xdx_905_ecustom--CommonSharesIssuedInSettlementOfAccountsPayableShares_c20251029__20251030__us-gaap--NatureOfExpenseAxis__custom--AccruedRentMember_zbg1papZ3Wy2" title="Stock issued in settlement of accounts payable, shares">11,500,000 shares of its common stock in exchange for accrued rent of $<span id="xdx_900_ecustom--CommonSharesIssuedInSettlementOfAccountsPayable_c20251029__20251030__us-gaap--NatureOfExpenseAxis__custom--AccruedRentMember_zvC6ZI2UhO96" title="Stock issued in settlement of accounts payable">5,750 (Note 8). The Company has recorded $500 and $3,250 rent payable to the stockholder in accounts payable as of December 31, 2025 and 2024, respectively. The Company executed three convertible promissory notes payable to a director (see Note E) for the principal amount of $125,000 and recorded accrued interest payable of $91,156 as of October 30, 2025. On October 30, 2025, the Company had a change of control in management, and mutually agreed with the holder of Note E to convert the principal balance of Note E of $125,000 and accrued interest of $91,156 as of date, in exchange for issuance of 180 shares of Series E Preferred Stock in full settlement of all balances due to Note E holder (Note 8). Accrued interest payable on Note E was $0 and $78,731 as of December 31, 2025 and 2024, respectively. Accrued dividend payable to this holder of Series E Preferred Stock totaled $3,720 as of December 31, 2025. On October 30, 2025, the Company entered into a Consulting Agreement (the “Consulting Agreement”) with Mr. Emmons pursuant to which Mr. Emmons agreed to receive a monthly fee of $<span id="xdx_90C_ecustom--MonthlyConsultingFee_c20251029__20251030__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmmonsMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zUtrJClBPSCc" title="Monthly consulting fee">4,167 payable in Series E Preferred Stock issuable no later than 15 days following the end of the month. The term of the Consulting Agreement is for three months, which is automatically renewable upon the consent of the parties for additional one-month terms. The Company has not issued Series E Preferred Stock for Mr. Emmon’s unpaid compensation for the two months as of December 31, 2025. Accrued dividend payable to this holder of Series E Preferred Stock totaled $<span id="xdx_90E_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmmonsMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zI2T3rE4Bseh">5,559 as of December 31, 2025. On October 30, 2025, the Company had a change in control and GHS Investments, LLP became the majority owner of the issued and outstanding shares of common and preferred stock (See Note 5 and Note 8).

1000 1000

3000

11500000 5750

500

3250

125000

91156

125000

91156

180

78731

3720

4167

5559

NOTE 8 – STOCKHOLDERS' EQUITY The Company has an authorized capital of 10,000,000,000 shares, $0.001 par value common stock, and 10,000,000 shares of $0.001 par value preferred stock at December 31, 2025. The Company has 586,285,063 shares of common stock, 100 shares of Series A Preferred Stock, 583 shares of Series B, 57 shares of Series C, 210 shares of Series D, and 1,207 shares of Series E Preferred Stock issued and outstanding as of December 31, 2025. Common Stock Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting rights. Holders of common stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the Board of Directors in its discretion of funds legally available, therefore. In the event of liquidation, dissolution, or winding up of the Company, the holders of common stock are entitled to share pro rata in all assets remaining after payment in full of all liabilities. All of the outstanding shares of common stock are fully paid and non-assessable. Holders of common stock have no preemptive rights to purchase the Company’s common stock. There are no conversion or redemption rights or sinking fund provisions with respect to the common stock. On October 30, 2025, the Company issued <span id="xdx_905_ecustom--CommonSharesIssuedInSettlementOfAccountsPayableShares_c20251029__20251030__us-gaap--NatureOfExpenseAxis__custom--AccruedRentMember_zt8PAm7M6AP7" title="Stock issued in settlement of accounts payable, shares">11,500,000 shares of common stock to a vendor in settlement of past due rent of $<span id="xdx_900_ecustom--CommonSharesIssuedInSettlementOfAccountsPayable_c20251029__20251030__us-gaap--NatureOfExpenseAxis__custom--AccruedRentMember_zK4yVuvMcEZk" title="Stock issued in settlement of accounts payable">5,750. In addition, on the same date, the Company issued <span id="xdx_905_ecustom--CommonSharesIssuedInSettlementOfAccountsPayableShares_c20251029__20251030__us-gaap--NatureOfExpenseAxis__custom--PaymentToVendorMember_zpMnFKBp1h93" title="Stock issued in settlement of accounts payable, shares">8,469,770 shares of common stock to a consultant in settlement of accounts payable of $<span id="xdx_903_ecustom--CommonSharesIssuedInSettlementOfAccountsPayable_c20251029__20251030__us-gaap--NatureOfExpenseAxis__custom--PaymentToVendorMember_z1XynZA3bIi4" title="Stock issued in settlement of accounts payable">4,235. The common shares issued were valued at the fair value of common stock on the date of issuance. Stock Incentive Plans On December 14, 2017, the Board of Directors adopted the 2017 Stock Incentive Plan (the “2017 Plan”), under which <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20171214__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_ziGz8hRo1YS8" title="Shares authorized under the plan">4,500,000 shares of common stock were authorized for issuance. The 2017 Plan was terminated effective December 31, 2025 pursuant to a resolution of the Board of Directors. On October 30, 2025, the Company cancelled <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCancelled_iI_c20251030__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_z8tfKU15Dpa3" title="Shares cancelled under the plan">952,212 unissued shares pursuant to the 2017 Plan. As of December 31, 2025, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zRd6oWa8BeA" title="Shares outstanding">0 shares remain unissued or unvested pursuant to the 2017 Plan. On December 14, 2017, the Board of Directors of the Company approved the 2017 Stock Incentive Plan (the “2017 Plan”). Awards may be made under the 2017 Plan for up to 4,500,000 shares of common stock of the Company. All of the Company's employees, officers and directors, as well as consultants and advisors to the Company are eligible to be granted awards under the 2017 Plan. No awards can be granted under the 2017 Plan after the expiration of 10 years from the plan approval but awards previously granted may extend beyond that date. Awards may consist of both incentive and non-statutory options, restricted stock units, stock appreciation rights, and restricted stock awards. The 2017 Plan was terminated effective December 31, 2025 pursuant to a resolution of the Board of Directors adopted on April 10, 2026. On March 11, 2019, the Board of Directors adopted the 2019 Stock Incentive Plan (the “2019 Plan”), under which <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20190311__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zMtlMubcMqx4" title="Shares authorized under the plan">5,000,000 shares of common stock were authorized for issuance. On March 5, 2025, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250304__20250305__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member__srt--CounterpartyNameAxis__custom--TwoConsultantsMember_z2D7bMFdJHuf" title="Stock issued for services, shares">200,000 common shares to two consultants for services rendered, valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250304__20250305__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member__srt--CounterpartyNameAxis__custom--TwoConsultantsMember_z9CDBxzhN08d" title="Stock issued for services, value">240, pursuant to the 2019 Plan. As of December 31, 2025, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190312__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_za0AJHu6m743" title="Shares awarded under the plan">3,530,000 shares had been awarded and <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zJbPAdtPgDI2" title="Shares outstanding">1,470,000 shares remained unissued. The 2019 Plan was terminated effective December 31, 2025 pursuant to a resolution of the Board of Directors. On March 18, 2022, the Board of Directors adopted the 2022 Stock Incentive Plan (the “2022 Plan”), under which <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20220318__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zWDjvBf3vqoe" title="Shares authorized under the plan">20,000,000 shares of common stock were authorized for issuance. The Company awarded 14,300,000 shares under the 2022 Plan, of which <span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zZg3iPDcuxG1" title="Shares issued under plan">14,200,000 had been issued as of December 31, 2025. On October 30, 2025, in connection with the change of control, 6,000,000 unvested shares were cancelled. As of December 31, 2025, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zIC9xPz70tP" title="Shares vested under the plan">100,000 shares remained vested and unissued (subsequently issued on March 23, 2026 - see Note 10) and <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_znKmTWMglJE6" title="Shares unvested under the plan">0 shares remained unvested. The 2022 Plan was terminated effective December 31, 2025 pursuant to a resolution of the Board of Directors. The 2022 Plan is further described in Note 4. On March 5, 2025, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250304__20250305__srt--CounterpartyNameAxis__custom--AnOfficerAndADirectorMember_za8hmqgDNIZ8" title="Stock issued for services, shares">5,000,000 shares to an officer and a director and 100,000 shares to an advisor, valued at $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250304__20250305__srt--CounterpartyNameAxis__custom--AnOfficerADirectorMemberAndAnAdvisorMember_z1h691vn4Lxd" title="Stock issued for services, value">6,120, being the fair value of common shares issued on the date of issuance. On June 23, 2025, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250622__20250623__srt--CounterpartyNameAxis__custom--AnOfficerAndADirectorMember_zbA3524iR5Q1" title="Stock issued for services, shares">6,000,000 shares to an officer and a director, valued at $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250622__20250623__srt--CounterpartyNameAxis__custom--AnOfficerAndADirectorMember_zV98kcfks1X3" title="Stock issued for services, shares">5,400 being the fair value of common shares issued on the date of issuance. On October 30, 2025, the Company had a change of control in management and mutually agreed to cancel 6,000,000 unissued and unvested shares of common stock pursuant to the 2022 Plan. At December 31, 2025, 100,000 shares of common stock remained vested and unissued pursuant to the 2022 Plan, and 0 shares of common stock remained unvested. On March 23, 2026, the Company issued the remaining 100,000 shares of common stock, fully vested, to the advisor (Note 10). The 2022 Plan was terminated effective December 31, 2025 pursuant to a resolution of the Board of Directors adopted on April 10, 2026. The common shares vested pursuant to the 2022 Plan amounted to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20250101__20251030__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zx8o2dPcGTz8" title="Shares vested in period">14,300,000 shares as of the change in control on October 30, 2025. For the year ended December 31, 2025 and 2024, the Company recorded $3,728 and $3,413 as stock compensation expense for <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zKdY8SyNLbl6" title="Stock issued for compensation, shares">4,734,247 shares and <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zsVpNVkwnBn" title="Stock issued for compensation, shares">4,515,068 shares, respectively. Shares earned and issued related to the consulting agreements are issued under the 2017 Plan and the 2019 Plan (see Note 4). Vesting of the shares is subject to acceleration of vesting upon the occurrence of certain events such as a Change of Control (as defined in the agreement) or the listing of the Company’s common stock on a senior exchange. A summary of the status of the Company’s non-vested shares at December 31, 2025 and 2024 and changes during the twelve months ended, is presented below: <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z0TlnxLCZSRi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Non-vested shares)"> <tr style="vertical-align: bottom"> <td style="display: none">Schedule of non-vested shares</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">2022 Stock Incentive Plan</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Shares of Common Stock</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Authorized shares per the 2022 Plan – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLSE9MREVSUycgRVFVSVRZIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zEsTV4kxz7G6" title="Authorized shares">20,000,000 shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%">Balance - December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zTw8CyMg8YWd" style="width: 13%; text-align: right" title="Shares of common stock, Beginning balance">14,300,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zeB5aKFmaHCl" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Awarded and issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zzhXGnEXpfTh" style="text-align: right" title="Shares of common stock, Awarded">3,100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zEsUDl998Cu2" style="text-align: right" title="Weighted average exercise price, Awarded">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zUq7qM7nVAJ" style="text-align: right" title="Shares of common stock, Vested">(8,100,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z6dr164ZfCw8" style="text-align: right" title="Weighted average exercise price, Vested">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zrlcYRXFwHig" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zbk895HtnE84" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Balance – December 31, 2024 – (Vested)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zCDBBJulglw2" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Vested">9,300,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z7SCgQ9F5sP5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Vested">0.006146</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance – December 31, 2024 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zlHSB5SUz3ra" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">6,100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zJ6HASQpoMa6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Balance - December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zdcEgSHPo4G6" style="text-align: right" title="Shares of common stock, Beginning balance">9,300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zQ6tmvA7UnV9" style="text-align: right" title="Weighted average exercise price, Beginning balance">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Awarded</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z68yoQPSU0K1" style="text-align: right" title="Shares of common stock, Awarded">11,100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zJgiWMOF7QSg" style="text-align: right" title="Weighted average exercise price, Awarded">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zsx7rZUoNWPk" style="text-align: right" title="Shares of common stock, Vested">(14,300,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zGgO918HrV53" style="text-align: right" title="Weighted average exercise price, Vested">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zQ717ySuw2J9" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">6,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zKk9cFE7E5Mf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Balance – December 31, 2025 – (Vested)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zJ7dlCWq6S5d" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Vested">100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z9OCF2tWhc5i" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Vested">0.006146</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance – December 31, 2025 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zlVJncerWDu7" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_d0_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z48txTyEO9jj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Preferred Stock Series A Supervoting Preferred Stock The Board of Directors of the Company authorized the issuance of 25,845 shares of preferred stock, $0.001 par value per share, designated as Series A Supervoting Preferred Stock. On October 30, 2025, the Company entered into a Stock Purchase Agreement with GHS Investments, LLC, a Nevada limited liability company (“GHS”), pursuant to which, upon occurrence of certain conditions, including defaults by the Company under its agreements with GHS and subsequent waivers and extensions thereof by GHS, the Company would issue to GHS 100 shares of the Company’s Series A Supervoting Preferred Stock. On November 5, 2025, the closing of the Stock Purchase Agreement occurred, and GHS was issued 100 shares of Series A Supervoting Preferred Stock. The following conditions were agreed and completed on the closing. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 2%"></td><td style="width: 2%">·</td><td style="text-align: justify; width: 96%">On November 5, 2025, the Company and Cliff Emmons, CEO of the Company, mutually agreed to cancel <span id="xdx_90D_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20251104__20251105__srt--CounterpartyNameAxis__custom--CliffEmmonsMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zLQIU7vyye1d" title="Stock cancelled during period, shares">7,800 shares of Series A Preferred Stock owned by Mr. Emmons.</td></tr> <tr style="vertical-align: top"> <td></td><td>·</td><td style="text-align: justify">On November 5, 2025, the Company and Mr. Mitta, independent Director of the Company, mutually agreed to cancel <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20251104__20251105__srt--CounterpartyNameAxis__custom--VidMittaMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zBJItU4wk0db" title="Stock cancelled during period, shares">12,000 shares of Series A Preferred Stock owned by Mr. Mitta.</td></tr> <tr style="vertical-align: top"> <td></td><td>·</td><td style="text-align: justify">On November 5, 2025, the Company and Ms. Karen McNemar, COO/Interim CFO of the Company, mutually agreed to cancel <span id="xdx_90D_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20251104__20251105__srt--CounterpartyNameAxis__custom--KarenMcNamerMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zy8IOvg7uFDj" title="Stock cancelled during period, shares">6,045 shares of Series A Preferred Stock owned by Ms. McNemar. </td></tr></table> Dividends: Initially, there will be no dividends due or payable on Series A Supervoting Preferred Stock. Any future terms with respect to dividends shall be determined by the Board consistent with the Company’s Articles of Incorporation. Liquidation and Redemption Rights: Upon the occurrence of a Liquidation Event (as defined below), the holders of Series A Supervoting Preferred Stock are entitled to receive net assets on a pro-rata basis. Each holder of Series A Supervoting Preferred Stock is entitled to receive ratably any dividends declared by the Board, if any, out of funds legally available for the payment of dividends. Liquidation Event means (i) the liquidation, dissolution or winding-up, whether voluntary or involuntary, of the Company, (ii) the purchase or redemption by the Company of the shares of any class of stock or the merger or consolidation of the Company with or into any other corporation or corporations, or (iii) the sale, license or lease of all or substantially all, or any material part of, the Company’s assets. Conversion: Each holder of Series A Supervoting Preferred Stock may voluntarily convert its shares into shares of common stock of the Company at a rate of 1:100 (as may be adjusted for any combinations or splits with respect to such shares). Rank: All shares of the Series A Supervoting Preferred Stock shall rank senior to the Company’s (A) common stock, par value $0.001 per share, and any other class or series of capital stock of the Company hereafter created. Voting Rights: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 2%"> </td> <td style="width: 2%">A.</td> <td style="text-align: justify; width: 96%">If at least one share of Series A Super Voting Preferred Stock is issued and outstanding, then the total aggregate issued shares of Series A Super Voting Preferred Stock at any given time, regardless of their number, shall have voting rights equal to 20 times the sum of: i) the total number of shares of Common stock which are issued and outstanding at the time of voting, plus ii) the total number of shares of all Series of Preferred stocks which are issued and outstanding at the time of voting.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>B.</td> <td style="text-align: justify">Each individual share of Series A Super Voting Preferred Stock shall have the voting rights equal to:</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify">[twenty times the sum of: {all shares of Common stock issued and outstanding at the time of voting + all shares of Series A and any newly designated Preferred stock issued and outstanding at the time of voting}]</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify">Divided by:</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify">[the number of shares of Series A Super Voting Preferred Stock issued and outstanding at the time of voting]</td></tr> </table> With respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of the outstanding shares of Series A Super Voting Preferred Stock shall vote together with the holders of Common Stock without regard to class, except as to those matters on which separate class voting is required by applicable law or the Articles of Incorporation or Bylaws. The Company had 100 shares and 25,845 shares of Series A Preferred Stock issued and outstanding at December 31, 2025 and 2024, respectively. Series B Convertible Preferred Stock Equity Financing On November 16, 2020, the Board of Directors of the Company had authorized issuance of up to 600 shares of preferred stock, $0.001 par value per share, designated as Series B Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series B Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series B Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series B Convertible Preferred Stock. From and after the initial Closing Date, in addition to the payment of dividends pursuant to Section 2(a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series B Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. Any dividends that are not paid shall continue to accrue and shall entail a late fee which must be paid in cash, at the rate of 18% per annum or lesser rate permitted by applicable law which shall accrue and compound daily from the dividend payment date through and including the date of actual payment in full. Redemption following the event of default shall occur at an amount equaling the product of one hundred thirty-five percent (135%), multiplied by the sum of the stated value, all accrued but unpaid dividends and all other amounts due pursuant to the certificate of designation for all purchased shares. The Holder of Series B Convertible Preferred Stock waived its rights to the event of default of an amount equal to the 135% multiplied by the sum of the stated value of Series B Convertible Preferred Stock for all accrued but unpaid dividends and all other amounts due pursuant to the certificate of designation for all purchased shares. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights: The Series B Convertible Preferred Stock will vote together with the common stock on an as converted basis subject to the Beneficial Ownership Limitations (not in excess of 4.99% conversion limitation). However, as long as any shares of Series B Convertible Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Series B Convertible Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Series b Convertible Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise Pari passu with, the Series B Convertible Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise Pari passu with, the Series b Convertible Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Series B Convertible Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing. Liquidation: Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Series B Convertible Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. Conversion: Each share of Series B Convertible Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of common stock (subject to the limitations) determined by dividing the Stated Value of such share of Series B Convertible Preferred Stock by the Conversion Price. The Conversion Price for the Series B Convertible Preferred Stock shall be the amount equal to the lowest traded price for the Company’s common stock for the fifteen (15) Trading Days immediately preceding the date of such conversion. All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the common stock during such a measuring period. Following an event of default, the Conversion price shall equal the lower of: (a) the then applicable Conversion Price; or (b) a price per share equaling 80% of the lowest traded price for the Company’s common stock during the ten (10) trading days preceding the relevant Conversion. Redemption: The Series B Convertible Preferred Stock may be redeemed by payment of the stated value thereof, with the following premiums based on the time of the redemption. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 2%"> </td> <td style="width: 2%">·</td> <td style="text-align: justify; width: 96%">115% of the stated value if the redemption takes place within 90 days of issuance</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">120% of the stated value if the redemption takes place after 90 days and within 120 days of issuance</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">125% of the stated value if the redemption takes place after 120 days and within 180 days of issuance; and</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">each share of Preferred Stock is redeemed one year from the day of issuance</td></tr> </table> November 19, 2020 On November 19, 2020, pursuant to the terms of a Securities Purchase Agreement dated November 16, 2020 (the “SPA”), the Company entered into a new preferred equity financing agreement with GHS Investments, LLC (“GHS”) in the amount of up to $600,000. The SPA provides GHS’s purchase, from time to time, of up to 600 shares of the newly designated Series B Convertible Preferred Stock. The initial closing under the SPA consisted of 45 shares of Series B Convertible Preferred Stock, stated value $1,200 per share, issued to GHS for an initial purchase price of $45,000, or $1,000 per share. At the Company’s option, and subject to the terms of the SPA and the Certificate of Designation for the Series B Convertible Preferred Stock (the “COD”), additional closings in the amount of 40 shares of Series B Convertible Preferred Stock for a total purchase price of $40,000 may take place at a rate of up to once every 30 days. In connection with the initial closing in the amount of 45 shares of Series B Convertible Preferred Stock, the Company issued an additional 25 shares of Series B Convertible Preferred Stock to GHS as a commitment fee. No additional closing may take place after the two-year anniversary of the SPA, or once the entire $600,000 amount has been funded. If the average daily trading volume for the Company’s common stock for the 30 trading days preceding a particular additional closing is at least $50,000 per day, the Company may, at its option, increase the amount of that additional closing to 75 shares of Series B Convertible Preferred Stock ($75,000). The Series B Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging, the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results for each reporting period. On November 19, 2020, GHS purchased a total of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zJORnuIkN07l" title="Stock issued new, shares">70 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zXk8rZsbB3m4" title="Proceeds from sale of stock">45,000 as a loss recorded on issuance to interest expense. The Company paid $<span id="xdx_90E_eus-gaap--PaymentsOfStockIssuanceCosts_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zbaHMF5A2X23" title="Payments of stock issuance costs">900 in selling commissions to complete this financing. On November 19, 2020 (the date of receipt of cash proceeds of $45,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90B_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zUY6myL4Oxaa">103,267, $<span id="xdx_90A_ecustom--DayOneLossOnDerivative_pp0p0_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zb7ZvMPdleY3">58,267 as day one loss on the derivative, $<span id="xdx_90A_eus-gaap--InterestExpenseDebt_pp0p0_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zoCvdQQfaDD7">39,000 as interest expense, and $<span id="xdx_905_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zU6QDfupiOLb">39,000 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zxemSI5n1t1k">45,000 as amortization. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a gain in connection with the change in fair market value of the derivative liability of $<span id="xdx_908_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zYnuGwirijO" title="Change fair market value of derivative liability">9,132 and a loss of $<span id="xdx_901_ecustom--DerivativeLossOnDerivative1_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_z7ETSBwoRKl5" title="Change fair market value of derivative liability">14,783 for the years ended December 31, 2025 and 2024, respectively. The Company recorded preferred dividend expense of $138,033 and $10,108 for the years ended December 31, 2025 and 2024, respectively. The Company recorded $<span id="xdx_903_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zRGHO13SrHT3" title="Preferred stock dividend payable">179,540 and $<span id="xdx_908_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zftySHHt6qKg" title="Preferred stock dividend payable">41,508 as preferred stock dividend payable as of December 31, 2025 and 2024, respectively. The preferred stock dividend payable at December 31, 2025 included $127,953 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $139,406 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_903_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zg6oopsUHcz4" title="Derivative liability payable">78,317 and $<span id="xdx_90F_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zIwHlG8HdxK4" title="Derivative liability payable">87,450 at December 31, 2025 and 2024, Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_90F_ecustom--MezzanineDerivativeLiability_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zvjezqYeDDHb" title="Mezzanine liability"><span id="xdx_901_ecustom--MezzanineDerivativeLiability_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zRGboG5rPhI3" title="Mezzanine liability">84,000 at December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0141, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0184, an expected dividend yield of 0%, expected volatility ranging from 160.41% to 440.99%, risk-free interest rates ranging from 0.07% to 5.46%, and an expected term ranging from 0.13 years to 1.50 years. December 16, 2020 On December 16, 2020, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zpUHRmJeeTZ2" title="Stock issued new, shares">85 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zKUj557CefWi" title="Issuance sale equity">85,000. The Company paid $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zTJ7sBjruAPg" title="Issuance cost">1,700 in selling commissions to complete this financing. On December 16, 2020 (the date of receipt of cash proceeds of $85,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zubFVedCl3q9">106,241, $<span id="xdx_90C_ecustom--DayOneLossOnDerivative_pp0p0_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_z1AB9vh02r66">21,241 as day one loss on the derivative, $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_pp0p0_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_z9whSpHrfmF5" title="Interest expense">17,000 as interest expense, and $<span id="xdx_905_ecustom--MezzanineDerivativeLiability_c20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0">17,000 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_902_eus-gaap--AmortizationOfDebtDiscountPremium_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0">85,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a gain of $<span id="xdx_908_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zstIIa9fn77b" title="Loss on derivative liability">11,089 and a loss of <span id="xdx_90E_ecustom--DerivativeLossOnDerivative1_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zADXJCV3CKVj" title="Loss on derivative liability">17,950 in connection with the change in fair market value of the derivative liability for the years ended December 31, 2025 and 2024, respectively. The Company recorded preferred stock dividend expense of $<span id="xdx_90A_eus-gaap--Dividends_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_z9MnDek9GH5j" title="Preferred stock dividend expense">166,478 and $<span id="xdx_901_eus-gaap--Dividends_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zF2YCq6NOGb4" title="Preferred stock dividend expense">12,274 for the years ended December 31, 2025, and 2024, respectively. The Company recorded $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zZLlZFWo0JN6" title="Preferred stock dividend payable">215,975 and $<span id="xdx_90A_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zG0vgXTz0pp5" title="Preferred stock dividend payable">49,497 as preferred stock dividend payable as of December 31, 2025 and 2024, respectively. The preferred stock dividend payable at December 31, 2025 included $154,238 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $170,902 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zZMrJDyBsh2c">95,099 and $<span id="xdx_90B_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_z34iwCqEcwwj">106,189 as of December 31, 2025 and 2024, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_905_ecustom--MezzanineDerivativeLiability_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_z2oEfYRhBOUa" title="Mezzanine liability"><span id="xdx_908_ecustom--MezzanineDerivativeLiability_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zsTnuqJWG4E8" title="Mezzanine liability">102,000 at December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0141, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0184, an expected dividend yield of 0%, expected volatility ranging from 160.41% to 437.59%, risk-free interest rates ranging from 0.07% to 5.46%, and an expected term ranging from 0.21 years to 1.50 years. December 20, 2021 On December 20, 2021, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zZUlhZvwT5Mi" title="Stock issued new, shares">51 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zcJ33bVL1CNa" title="Issuance sale equity">51,000. The Company paid $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zGLrqAyQXEka" title="Issuance cost">1,000 in selling commissions to complete this financing. For the year ended December 31, 2021, the Company inadvertently reported this sale of <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zWWsboHuzM8b" title="Number of shares sold">51 shares as Series A Preferred stock (See Series A Supervoting Preferred Stock). The accompanying financial statements reflect the correct purchase of Series B Convertible Preferred Stock rather than Series A Convertible Preferred Stock. The overall effect of this correction was not significant to the December 31, 2021 financial statements. The Company recalculated the value of the derivative liability associated with this convertible preferred stock in connection with the change in fair market value of the derivative liability and recorded a gain of $<span id="xdx_905_ecustom--DerivativeLossOnDerivative1_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zNvJ1rhdhpac" title="Loss on derivative liability">6,654 and a loss of <span id="xdx_901_ecustom--DerivativeLossOnDerivative1_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zoWqQbxiCLT4" title="Loss on derivative liability">10,770 for the years ended December 31, 2025 and 2024, respectively. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recorded preferred stock dividend expense of $<span id="xdx_908_eus-gaap--Dividends_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zi6vSOmNOfh6" title="Preferred stock dividend expense">66,997 and $<span id="xdx_901_eus-gaap--Dividends_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zJ86EwR1ZUSa" title="Preferred stock dividend expense">7,364 for the years ended December 31, 2025 and 2024, respectively. The Company recorded $<span id="xdx_901_eus-gaap--DividendsPayableCurrent_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_z5T4XdkyE1bg" title="Preferred stock dividend payable">89,270 and $<span id="xdx_901_eus-gaap--DividendsPayableCurrent_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zHtwnJ4aIWp7" title="Preferred stock dividend payable">22,273 as preferred stock dividend payable as of December 31, 2025 and 2024, respectively. The preferred stock dividend payable at December 31, 2025 included $59,653 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $85,604 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_908_ecustom--DerivativeLiabilityCurrent_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_z5PMHKsc9Kk8" title="Derivative liability payable">57,060 and $<span id="xdx_907_ecustom--DerivativeLiabilityCurrent_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_z3bMI4TvH4j5" title="Derivative liability payable">63,713 as of December 31, 2025 and 2024, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_903_ecustom--MezzanineDerivativeLiability_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zpgC8m3NmjUg"><span id="xdx_902_ecustom--MezzanineDerivativeLiability_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zIyw71oEKbIh">61,200 as of December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0050 the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0070, an expected dividend yield of 0%, expected volatility ranging from 174.58% to 221.64%, risk-free interest rates ranging from 0.91% to 5.46%, and an expected term of 1.50 years. February 7, 2022 On February 7, 2022, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zBON4Cd6I6s2" title="Number of shares issued, shares">51 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zcK6QUPkzZOi" title="Gross proceeds">51,000. The Company paid $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_z9tJL8Ywj0tj" title="Selling commissions paid">1,000 in selling commissions to complete this financing. On February 7, 2022 (the date of receipt of cash proceeds of $51,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_903_ecustom--InitialDerivativeLiability_iI_c20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zwTFcbGHYhva" title="Initial derivative liability">65,025, $<span id="xdx_90C_ecustom--DayOneLossOnDerivative_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zTUW3COr1TVe" title="Day one loss on derivative">14,025 as day one loss on the derivative, $<span id="xdx_902_eus-gaap--InterestExpenseOther_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zDSQr3pYO3lb">10,200 as interest expense, and $10,200 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zGLaIcZ8Myg7">51,000 as a loss recorded on issuance to interest. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a gain of $<span id="xdx_90E_ecustom--DerivativeLossOnDerivative1_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zh6CG3QQfufa">6,654 and a loss of $<span id="xdx_90C_ecustom--DerivativeLossOnDerivative1_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zMh5WXZJjYz2">10,770 in connection with the change in fair market value of the derivative liability for the years ended December 31, 2025 and 2024, respectively. In addition, the Company recorded $<span id="xdx_906_eus-gaap--Dividends_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zvxHBlToex4e">61,759 and $<span id="xdx_90C_eus-gaap--Dividends_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zfZrgdekPhE3">7,364 as preferred stock dividend expense for the years ended December 31, 2025 and 2024, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_909_eus-gaap--DividendsPayableCurrent_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zJMntHyjPUBh">83,045 and $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zyoRYuBQCy3h">21,288 as of December 31, 2025 and 2024, respectively. The preferred stock dividend payable at December 31, 2025 included $54,415 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $82,787 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_90E_ecustom--DerivativeLiabilityCurrent_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zuNzKSDeeHGg">57,060 and $<span id="xdx_908_ecustom--DerivativeLiabilityCurrent_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zEzTrh35CsT7">63,713 as of December 31, 2025 and 2024, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_90B_ecustom--MezzanineDerivativeLiability_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zpZk0CYGPid4"><span id="xdx_909_ecustom--MezzanineDerivativeLiability_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zj2IVSqGCAdb">61,200 as of December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0096, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0172, an expected dividend yield of 0%, expected volatility ranging from 160.35% to 201.38%, risk-free interest rates ranging from 1.09% to 5.46%, and an expected term of 1.35 to 1.5 years. March 24, 2022 On March 24, 2022, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zDQfgMztQ8Eh" title="Number of shares issued, shares">136 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zhWDRqIdVsvh" title="Gross proceeds">136,000. The Company paid $<span id="xdx_903_eus-gaap--PaymentsOfStockIssuanceCosts_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_z2AQYfiJ49L8" title="Selling commissions paid">2,720 in selling commissions to complete this financing. On March 24, 2022 (the date of receipt of cash proceeds of $136,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90E_ecustom--InitialDerivativeLiability_iI_pp0p0_c20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zwOZP8yeUF1i">328,422, $<span id="xdx_902_ecustom--DayOneGainOnDerivative_pp0p0_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zfje5bgE3Cyd">192,422 as day one loss on the derivative, $<span id="xdx_907_eus-gaap--InterestExpenseOther_pp0p0_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zqpppIPUaEMi">27,200 as interest expense, and $<span id="xdx_902_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zRuBRTkYQmnk">27,200 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_906_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zN7NYnK4N8Nk">136,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a gain of $<span id="xdx_90B_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zhevvt07CBR">17,743 and a loss of $<span id="xdx_90D_ecustom--DerivativeLossOnDerivative1_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_ziKKoXPx4oMi">28,720 for the years ended December 31, 2025 and 2024, respectively. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_90B_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zwkMAFn7p8Rl">151,147 and $<span id="xdx_90B_eus-gaap--Dividends_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zc4qvPUmHVGl">19,638 for the years ended December 31, 2025 and 2024, respectively. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_90E_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zCWFfEXVW6gf">205,500 and $<span id="xdx_900_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_z7GGoje7Lrf9"><span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zk3hCxQ7LAw3">54,352 as of December 31, 2025 and 2024. The preferred stock dividend payable at December 31, 2025 included $131,563 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $213,765 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_90D_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_ztwCllrOShNf">152,159 and $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zoZzF3MMuIug">169,902 as of December 31, 2025 and 2024, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_90F_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zflRrRMaIOKi" title="Mezzanine liability"><span id="xdx_908_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zpv6FKxKO1Gb" title="Mezzanine liability">163,200 as of December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0096, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0018, an expected dividend yield of 0%, expected volatility ranging from 160.35% to 202.70%, risk-free interest rates ranging from 1.55% to 5.46%, and an expected term of 1.48 to 1.5 years. November 17, 2022 On November 17, 2022, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zAyC4WAVKHok">61 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Proceeds from sale of equity">61,000. The Company paid $<span id="xdx_90B_eus-gaap--PaymentsOfStockIssuanceCosts_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Payments of stock issuance costs">1,220 in selling commissions to complete this financing. On November 17, 2022 (the date of receipt of cash proceeds of $61,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_903_ecustom--InitialDerivativeLiability_iI_pp0p0_c20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zG3AFv02o2jh">54,072, $<span id="xdx_90C_ecustom--DayOneGainOnDerivative_pp0p0_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_z9rXWHUtN41e">6,928 as day one gain on the derivative, $<span id="xdx_90C_eus-gaap--InterestExpenseOther_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0">12,200 as interest expense, $<span id="xdx_908_ecustom--MezzanineDerivativeLiability_c20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0">12,200 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_907_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zgppDR0umdHi">61,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a gain of $<span id="xdx_907_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zFQblBFLMDh7">7,958 and a loss of $<span id="xdx_906_ecustom--DerivativeLossOnDerivative1_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zSwpOJX0X5Wi">12,882 for the years ended December 31, 2025 and 2024, respectively. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_905_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zuzRP2Fe057d">56,348 and $<span id="xdx_900_eus-gaap--Dividends_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zEE1wGCz3uT2">8,808 for the years ended December 31, 2025 and 2024, respectively. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_90A_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zp5dyiFqT0m">74,999 and $<span id="xdx_90A_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zXMMpW1hIl12">18,651 as of December 31, 2025 and 2024. The preferred stock dividend payable at December 31, 2025 included $47,564 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $85,326 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_902_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zfUtz6XsXHyc">68,248 and $<span id="xdx_901_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zrQJMSMfU3Ze">76,206 at December 31, 2025 and 2024, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_90E_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zCxVJ16GS2B6" title="Mezzanine liability"><span id="xdx_907_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zeKNWqYzyFl4" title="Mezzanine liability">73,200 at December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0020, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0022, an expected dividend yield of 0%, expected volatility ranging from 174.58% to 201.59%, risk-free interest rates ranging from 3.68% to 5.46%, and an expected term of 1.5 years. August 24, 2023 On August 24, 2023, pursuant to the terms of the SPA, GHS purchased <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zXqawPbKVni4">62 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zYcAExW6V4H4">62,000. The Company paid $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zViolQIAxg4j">1,240 in selling commissions to complete this financing. On August 24, 2023 (the date of receipt of cash proceeds of $62,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_909_ecustom--InitialDerivativeLiability_iI_pp0p0_c20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zguZe5QcoqQb" title="Initial derivative liability">61,679, $<span id="xdx_90F_ecustom--DayOneGainOnDerivative_pp0p0_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zZfZ2yaWh7Wd" title="Day one gain on derivative">321 as day one gain on the derivative, $<span id="xdx_905_eus-gaap--InterestExpenseOther_pp0p0_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zlPbiHInnDjg" title="Interest expense">12,400 as interest expense, and $<span id="xdx_90A_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zrLccG9SMqK8" title="Mezzanine derivative liability">12,400 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zl4aFTjgKrr7" title="Amortization expenses">62,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible in connection with the change in fair market value of the derivative liability note and recorded a gain of $<span id="xdx_90A_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zB0693PAfKFc">8,144 and a loss of $<span id="xdx_902_ecustom--DerivativeLossOnDerivative1_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_ztXaEMd8LDW5">13,100 for the years ended December 31, 2025 and 2024, respectively. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_90F_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_z1MtUd3ptUEh">50,373 and $<span id="xdx_90F_eus-gaap--Dividends_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zOlj3a1fabV7">8,952 for the years ended December 31, 2025 and 2024, respectively. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_905_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zkEWcEyL0Xo5">62,481 and $<span id="xdx_906_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zlnYuWTavhYl">12,108 as of December 31, 2025 and 2024, respectively. The preferred stock dividend payable at December 31, 2025 included $41,445 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $75,541 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_907_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zxXWi41dGhNg">69,367 and $<span id="xdx_907_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zPe4oIF4XA1l">77,511 as of December 31, 2025 and 2024, and Series B Convertible Preferred Stock mezzanine liability was $74,400 at December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0014, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0015, an expected dividend yield of 0%, expected volatility ranging from 189.98% to 202.70%, risk-free interest rates ranging from 3.48% to 5.46%, and an expected term of 1.5 years. April 16, 2024 On April 16, 2024, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zIbNH7Eqq4H9">20 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zRbm3gcgCxvj">17,600. The Company paid $<span id="xdx_905_eus-gaap--PaymentsOfStockIssuanceCosts_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zwtGal3JfjW">2,400 in selling commissions to complete this financing. On April 16, 2024 (the date of receipt of cash proceeds of $17,600 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_904_ecustom--InitialDerivativeLiability_iI_pp0p0_c20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zOe3ekiVqH5d">20,324, $<span id="xdx_90A_ecustom--DayOneGainOnDerivative_pp0p0_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zli7xEG3kTMd">321 as day one loss on the derivative, $<span id="xdx_906_eus-gaap--InterestExpenseOther_pp0p0_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zbeCSpHHURu9">4,000 as interest expense, and $<span id="xdx_909_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zaxz9g8gtjmf">24,000 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zcywQBOJpQ8c">20,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a gain of $<span id="xdx_908_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zi5ImaqjmhX3">2,419 and a loss of $<span id="xdx_901_ecustom--DerivativeLossOnDerivative1_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zs0xW5PWekWi">1,965 for the years ended December 31, 2025 and 2024, respectively. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_904_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zNVrQFr0VVJ7">7,766 and $<span id="xdx_908_eus-gaap--Dividends_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zrJLZBDiAPr2">2,044 for the years ended December 31, 2025 and 2024, respectively. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_905_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zddQF6fOAzxd">9,810 and $<span id="xdx_904_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zLctoW3MlD3k">2,044 as of December 31, 2025 and 2024, respectively. The preferred stock dividend payable at December 31, 2025 included $4,886 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $9,915 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_90A_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zgJpcTB22L3b">19,870 and $<span id="xdx_906_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zk2fQHZFV4rk">22,289 as of December 31, 2025 and 2024, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_908_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zfQ6uRuzJzea"><span id="xdx_904_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zgCF1HTvxqQe">24,000 as of December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0009, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0014, an expected dividend yield of 0%, expected volatility ranging from 186.23% to 205.33%, risk-free interest rates ranging from 3.48% to 5.18%, and an expected term of 1 year. October 3, 2024 On October 3, 2024, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zcFOOy5Rq7R4">43 shares of Series B Convertible Preferred Stock and committed an additional 4 shares for services/fees for gross consideration of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zxCXBHOFNGei">43,000. The Company paid $<span id="xdx_90E_eus-gaap--PaymentsOfStockIssuanceCosts_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zCQJgkGNSUTh">3,860 in selling commissions and legal fees to complete this financing. On October 3, 2024 (the date of receipt of cash proceeds of $39,140), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_906_ecustom--InitialDerivativeLiability_iI_pp0p0_c20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zM0fGbFcXDyb">43,000, $<span id="xdx_906_ecustom--DayOneGainOnDerivative_pp0p0_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_z00PMfcpnMIb">11,480 as day one loss on the derivative, $<span id="xdx_90A_eus-gaap--InterestExpenseOther_pp0p0_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zKAopCnOT6Xi">8,600 as interest expense, and $<span id="xdx_90D_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zMJAfCsuLTok">51,600 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_z2w3SFeApiAh">39,140 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a gain of $<span id="xdx_90D_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zbHMFOH7kLN5">5,685 and a gain of $<span id="xdx_901_ecustom--DerivativeLossOnDerivative1_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zWTmm6eKLe11">2,951 for the years ended December 31, 2025 and 2024, respectively. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_90D_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_z8TxZ51PdtV9">15,399 and $<span id="xdx_903_eus-gaap--Dividends_pp0p0_c20240101__20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_z1qH3R0Yh2g1">1,650 for the years ended December 31, 2025 and 2024, respectively. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_904_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_z7PQxZ08t8F9">17,049 and $<span id="xdx_906_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_znbG4vQJmoni">1,650 as of December 31, 2025 and 2024, respectively. The preferred stock dividend payable at December 31, 2025 included $8,491 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $21,531 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_907_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_z5LPYRFcJnmk">646,694 and $<span id="xdx_90A_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zWUGJHlRDOm8">52,378 as of December 31, 2025 and December 31, 2024, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_908_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zn5GYdBQ7tb7"><span id="xdx_905_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20241231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zqWXMPAsf6R9">56,400 as of December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0009, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0012, an expected dividend yield of 0%, expected volatility ranging from 182.85% to 201.59%, risk-free interest rates ranging from 3.48% to 4.16%, and an expected term of 1 year. Series C Convertible Preferred Stock On January 8, 2024, the Board of Directors of the Company had authorized issuance of up to 5,000 shares of preferred stock, $0.001 per share, designated as Series C Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series C Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series C Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series C Convertible Preferred Stock. From and after the issuance date, in addition to the payment of dividends pursuant to Section 3 (a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series C Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights: The Holder shall be entitled to vote on an as-converted basis (subject to the Beneficial Ownership Limitation), together with the holders of Common Stock, with respect to any question upon which the holders of Common Stock have the right to vote, except as may be otherwise provided by applicable law. Except as otherwise expressly provided herein or as required by law, the Holders of Series C Preferred Stock and the holders of Common Stock shall vote together and not as separate classes. Liquidation: Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be paid, in preference and prior to any payment made to the holders of the Junior Securities and any other stock ranking in liquidation junior to the Series C Preferred Stock, an amount per share equal to the Stated Value (such amount is referred to herein as the “Liquidation Preference”). If upon a Liquidation Event, the assets to be distributed among the Holders shall be insufficient to permit payment in full to the Holders of the Liquidation Preference, then the entire assets of the Company shall be distributed ratably among such holders in proportion to the full respective Liquidation Preference to which they are entitled. Conversion: The Holder shall have the right, at any time to convert such shares into Common Stock into that number of shares of common stock (subject to the Beneficial Ownership Limitation (as defined below)) determined by dividing the Stated Value of such share of Series C Preferred Stock by the Optional Conversion Rate (as defined below) (each, and “Optional Conversion”) at a conversion rate of the volume-weighted average price (“VWAP”) for the Company’s common stock for the ten (10) Trading Days immediately preceding the date of such conversion (the “Optional Conversion Rate”). “Trading Days” shall mean a day on which the means the principal markets or exchange on which the common stock is listed or quoted for trading on the date in question is open for business. “Beneficial Ownership Limitation” shall mean 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Series C Preferred Stock held by the applicable Holder. No fractional shares of Common Stock shall be issued upon conversion of shares of Series C Preferred Stock. If more than one share of Series C Preferred Stock shall be surrendered, or deemed surrendered, pursuant to subsection (c) above, for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of such Series C Preferred Stock so surrendered. Any fractional share which would otherwise be issuable upon conversion of any shares of Series C Preferred Stock (after aggregating all shares of Series C Preferred Stock held by each holder) shall be rounded to the nearest whole number (with one-half being rounded upward). The Company shall reserve, free from preemptive rights, out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series C Preferred Stock sufficient shares to provide for the conversion of all outstanding shares of Series C Preferred Stock. All shares of Common Stock which may be issued in connection with the conversion provisions set forth herein will, upon issuance by the Company, be validly issued, fully paid and non-assessable, with no personal liability attaching to the ownership thereof, and free from all taxes, liens or charges with respect thereto. All shares of Series C Preferred Stock which have been converted shall no longer be deemed to be outstanding and all rights with respect to such shares including the rights to receive dividends and to vote, shall immediately cease and terminate on the Optional Conversion Date, except only the right of the Holder thereof to receive shares of Common Stock in exchange thereof. The Series C Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging, the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results each reporting period. March 1, 2024 On March 1, 2024, a convertible promissory noteholder and the Company mutually agreed to convert the principal balance of $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z8ZPYCK6vJoh" title="Converted principal balance">55,000 and accrued interest of $<span id="xdx_90E_ecustom--DebtConversionConvertedInterestAmount1_pp0p0_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zZOGVXVBOrRf" title="Accrued interest">13,825 into a total of <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zYFA5bFkWsz8" title="Converted shares issued">57 shares of Series C Convertible Preferred Stock. The Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90F_ecustom--InitialDerivativeLiability_iI_c20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zYGPhTU9Tell">40,668, $<span id="xdx_903_eus-gaap--InterestExpenseOther_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_z0qxl51DNFYb">425 as contra interest expense, $28,157 as day one gain on the derivative, $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_z4pFR5mlwX5c">68,825 as amortization expense, and $<span id="xdx_907_ecustom--MezzanineDerivativeLiability_iI_c20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zLCmqKE7ZBr5">68,825 as Series C Convertible Preferred Stock mezzanine liability. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with this convertible preferred stock in connection with the change in fair market value of the derivative liability and recorded a gain of $<span id="xdx_907_ecustom--DerivativeLossOnDerivative1_c20250101__20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zVccEfWlJV2a">9,721 and a loss of $<span id="xdx_908_ecustom--DerivativeLossOnDerivative1_c20240101__20241231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zkt0JyPISaLf">3,226 for the years ended December 31, 2025 and 2024, respectively. The Company recorded $<span id="xdx_90B_eus-gaap--Dividends_c20250101__20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zQ4iGVWQaE47">19,471 and $<span id="xdx_906_eus-gaap--Dividends_c20240101__20241231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zgjexyjvNQtj">6,859 as preferred stock dividend expense for the years ended December 31, 2025 and 2024, respectively. The Company recorded $<span id="xdx_905_eus-gaap--DividendsPayableCurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zn259yYqDXT9">26,330 and $<span id="xdx_907_eus-gaap--DividendsPayableCurrent_iI_c20241231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zfNnJtm2NEse">6,859 as preferred stock dividend payable as of December 31, 2025 and 2024, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_903_ecustom--DerivativeLiabilityCurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zuJ9bTTQVmG1">39,223 and $<span id="xdx_908_ecustom--DerivativeLiabilityCurrent_iI_c20241231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zCDqpTMpLPHh">43,894 as of December 31, 2025 and 2024, and Series C Convertible Preferred Stock mezzanine liability was $<span id="xdx_904_ecustom--MezzanineDerivativeLiability_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zuGN4dUHRJH4"><span id="xdx_905_ecustom--MezzanineDerivativeLiability_iI_c20241231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zlhy4PUOMJmj">68,400 as of December 31, 2025 and 2024, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.00138, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0014, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 202.70%, risk-free interest rates ranging from 3.48% to 5.09%, and an expected term of 1 year. Series D Convertible Preferred Stock On March 17, 2025, the Board of Directors of the Company had authorized issuance of up to <span id="xdx_909_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20250317__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zMydtlgY6tNk" title="Temporary equity, shares authorized">210 shares of preferred stock, $0.001 par value per share, designated as Series D Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series D Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series D Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series D Convertible Preferred Stock. From and after the issuance date, in addition to the payment of dividends pursuant to Section 3 (a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series D Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. Any dividends that are not paid shall continue to accrue and shall entail a late fee which must be paid in cash, at the rate of 18% per annum or lesser rate permitted by applicable law which shall accrue and compound daily from the dividend payment date through and including the date of actual payment in full. Redemption following the event of default shall occur at an amount equaling the product of one hundred thirty-five percent (135%), multiplied by the sum of the stated value, all accrued but unpaid dividends and all other amounts due pursuant to the certificate of designation for all purchased shares. The Holder of Series D Convertible Preferred Stock waived its rights to the event of default of an amount equal to the 135% multiplied by the sum of the stated value of Series D Convertible Preferred Stock for all accrued but unpaid dividends and all other amounts due pursuant to the certificate of designation for all purchased shares. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights: The Holder shall be entitled to vote on an as-converted basis (subject to the Beneficial Ownership Limitation), together with the holders of Common Stock, with respect to any question upon which the holders of Common Stock have the right to vote, except as may be otherwise provided by applicable law. Except as otherwise expressly provided herein or as required by law, the Holders of Series D Preferred Stock and the holders of Common Stock shall vote together and not as separate classes. Liquidation: Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be paid, in preference and prior to any payment made to the holders of the Junior Securities and any other stock ranking in liquidation junior to the Series D Preferred Stock, an amount per share equal to the Stated Value (such amount is referred to herein as the “Liquidation Preference”). If upon a Liquidation Event, the assets to be distributed among the Holders shall be insufficient to permit payment in full to the Holders of the Liquidation Preference, then the entire assets of the Company shall be distributed ratably among such holders in proportion to the full respective Liquidation Preference to which they are entitled. Conversion: The Holder shall have the right, at any time to convert such shares into Common Stock into that number of shares of common stock (subject to the Beneficial Ownership Limitation (as defined below)) determined by dividing the Stated Value of such share of Series D Preferred Stock by the Optional Conversion Rate (as defined below) (each, and “Optional Conversion”) at a conversion rate of the volume-weighted average price (“VWAP”) for the Company’s common stock for the ten (10) Trading Days immediately preceding the date of such conversion (the “Optional Conversion Rate”). “Trading Days” shall mean a day on which the means the principal markets or exchange on which the common stock is listed or quoted for trading on the date in question is open for business. “Beneficial Ownership Limitation” shall mean 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Series D Preferred Stock held by the applicable Holder. No fractional shares of Common Stock shall be issued upon conversion of shares of Series D Preferred Stock. If more than one share of Series D Preferred Stock shall be surrendered, or deemed surrendered, pursuant to subsection (c) above, for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of such Series D Preferred Stock so surrendered. Any fractional share which would otherwise be issuable upon conversion of any shares of Series D Preferred Stock (after aggregating all shares of Series D Preferred Stock held by each holder) shall be rounded to the nearest whole number (with one-half being rounded upward). The Company shall reserve, free from preemptive rights, out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series D Preferred Stock sufficient shares to provide for the conversion of all outstanding shares of Series D Preferred Stock. All shares of Common Stock which may be issued in connection with the conversion provisions set forth herein will, upon issuance by the Company, be validly issued, fully paid and non-assessable, with no personal liability attached to ownership thereof, and free from all taxes, liens or charges with respect thereto. All shares of Series D Preferred Stock which have been converted shall no longer be deemed to be outstanding and all rights with respect to such shares including the rights to receive dividends and to vote, shall immediately cease and terminate on the Optional Conversion Date, except only the right of the Holder thereof to receive shares of Common Stock in exchange thereof. The Series D Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging, the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results for each reporting period. March 21, 2025 On March 21, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zGFN8QRtri59">60 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zri1JpI1b3V5">60,000. The Company paid $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zuIKtXWa48n8">9,200 in selling commissions and legal fees to complete this financing. On March 21, 2025 (the date of receipt of cash proceeds of $50,800), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90F_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zmMezNB85C0e">65,024, $<span id="xdx_903_ecustom--DayOneGainOnDerivative_pp0p0_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zIMpIUEH2aqf">14,224 as day one loss on the derivative, $<span id="xdx_907_eus-gaap--InterestExpenseOther_pp0p0_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zeoWbmVLoLsa">12,000 as interest expense, and $<span id="xdx_90B_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_z0oO0QYiGyLa">72,000 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zjFopbWwALdk">50,800 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_901_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zwi01IYttF4g">12,946 for the year ended December 31, 2025. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_90A_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zxdMbaeD8ZG">14,374 for the year ended December 31, 2025. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_900_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zWfoB6Kw0tm8">14,374 as of December 31, 2025. The preferred stock dividend payable at December 31, 2025 included $7,628 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $25,326 for non-payment of dividend as of December 31, 2025. The Company did not record the waived penalty in its financial statements as of December 31, 2025 and 2024, respectively. The derivative liability payable for this transaction totaled $<span id="xdx_903_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zAoTO4b9Sh88">77,970 as of December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_90F_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zwXvQ9m8Ru8a">72,000 at December 31, 2025. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0008, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.001, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.73%, risk-free interest rates ranging from 3.48% to 4.04%, and an expected term of 1 year. April 10, 2025 On April 10, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zt0mhT97w8Sk">45 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zc2QTuBTkhsf">45,000. The Company paid $<span id="xdx_90C_eus-gaap--PaymentsOfStockIssuanceCosts_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zJpHDipNWhk6">900 in selling commissions and legal fees to complete this financing. On April 10, 2025 (the date of receipt of cash proceeds of $44,100), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_903_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zciuJA7ryBw4">57,220, $<span id="xdx_902_ecustom--DayOneGainOnDerivative_pp0p0_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zkO4ogmpjlMb">12,220 as day one loss on the derivative, $<span id="xdx_902_eus-gaap--InterestExpenseOther_pp0p0_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zsjaFEInQo1l">9,000 as interest expense, and $<span id="xdx_905_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zbJrg3whTEw7">54,000 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_902_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zBSq3emF5oHi">45,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_90B_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zVyp2P8IUEHi">1,257 for the year ended December 31, 2025. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_903_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_z91iBbSCbun5">5,193 for the year ended December 31, 2025. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_902_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zsFBJjD2jaIh">5,193 as of December 31, 2025. The preferred stock dividend payable at December 31, 2025 included $488 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. The derivative liability payable for this transaction totaled $<span id="xdx_90A_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zmF3gZbPLph9">58,477 as of December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_900_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zUm386hmsCLc">54,000 as of December 31, 2025. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.89%, risk-free interest rates ranging from 3.48% to 3.97%, and an expected term of 1 year. May 14, 2025 - 1 On May 14, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zvXN5Ve1FQ0h">11 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zivEORrJVfIl">11,000. The Company paid $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zQVJfLkQDCEk">220 in selling commissions and legal fees to complete this financing. On May 10, 2025 (the date of receipt of cash proceeds of $10,780), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_906_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zei1rZkHUfT6">13,815, $<span id="xdx_900_ecustom--DayOneGainOnDerivative_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_z0ZlupQVBnCc">2,815 as day one loss on the derivative, $<span id="xdx_90C_eus-gaap--InterestExpenseOther_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zhguPYpXxBOe">2,200 as interest expense, $<span id="xdx_904_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_z1GVXrP4QV9">13,815 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90A_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zbMaLiUKUgll">11,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_903_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zkq5Wxve7Q42">479 for the year ended December 31, 2025. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_908_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zEVuVrnKNo54">1,111 for the year ended December 31, 2025. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_907_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_z34qyD8gwPad">1,111 as of December 31, 2025. The preferred stock dividend payable at December 31, 2025 included $109 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. The derivative liability payable for this transaction totaled $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zRNzBt8xC4Lj">14,294 as of December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_909_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zbSZ0evw95c3">13,200 as of December 31, 2025. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.89%, risk-free interest rates ranging from 3.48% to 4.14%, and an expected term of 1 year. May 14, 2025 - 2 On May 14, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zLs3QByx3c5j">25 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zEWVidkhvWUk">25,000. The Company paid $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_z4FdZQUEcZAg">500 in sales commission and legal fees to complete this financing. On May 10, 2025 (the date of receipt of cash proceeds of $24,500), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_900_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zXuicrMZmLzg">31,399, $<span id="xdx_907_ecustom--DayOneGainOnDerivative_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_z41WvhLqG3Gh">6,399 as day one loss on the derivative, $<span id="xdx_90E_eus-gaap--InterestExpenseOther_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_z0NCdOxKR7Vc">5,000 as interest expense, $<span id="xdx_90B_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zsgQYnDjdDRk">13,815 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_z7nbOVO59wgf">11,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_901_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_z5cmlI4t2zD9">1,089 for the year ended December 31, 2025. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_908_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zBY9cuTHcM14">2,526 for the year ended December 31, 2025. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_90F_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zhlamXjvMk92">2,526 as of December 31, 2025. The preferred stock dividend payable at December 31, 2025 included $248 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. The derivative liability payable for this transaction totaled $<span id="xdx_90D_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zWeaNtHuwuc">32,487 as of December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_90A_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zKAg58UaBzc8">30,000 as of December 31, 2025. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.89%, risk-free interest rates ranging from 3.48% to 4.14%, and an expected term of 1 year. October 30, 2025 On October 30, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zZRUYJnKskDd">35 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zgXZ0apRJZ7j">35,000. The Company paid $<span id="xdx_907_eus-gaap--PaymentsOfStockIssuanceCosts_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_z6FSGRoWmXU5">700 in selling commissions and legal fees to complete this financing. On October 30, 2025 (the date of receipt of cash proceeds of $34,300), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90B_ecustom--InitialDerivativeLiability_iI_pp0p0_c20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_z4933fFQIA2j">28,724, $<span id="xdx_907_ecustom--DayOneGainOnDerivative_pp0p0_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zTlxrj7VBKwb">6,276 as day one loss on the derivative, $<span id="xdx_902_eus-gaap--InterestExpenseOther_pp0p0_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zZEKqffusAZ">7,000 as interest expense, $<span id="xdx_902_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zQOztt5ChXXe">7,000 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zHZVVDBGsm6j">35,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_907_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zrvhfagGFS76">16,758 for the year ended December 31, 2025. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_903_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zKHMiVrqQb2">1,099 for the year ended December 31, 2025. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_900_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zft5vorewzMf">1,099 as of December 31, 2025. The preferred stock dividend payable at December 31, 2025 included $243 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. The derivative liability payable for this transaction totaled $<span id="xdx_905_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zzaZ7KPx1Yuh">45,482 as of December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_90E_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zZM29aqnrvj">42,000 as of December 31, 2025. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0005 to $0.0006, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0005 to $0.0007, an expected dividend yield of 0%, expected volatility ranging from 198.09% to 198.95%, risk-free interest rates ranging from 3.48% to 3.70%, and an expected term of 1 year. December 2, 2025 On December 2, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zSTPUpCKUzPe">34 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zl9y1LkaV1Tl">34,000. The Company paid $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zoq31lN7oIra">680 in sales commissions and legal fees to complete this financing. On December 2, 2025 (the date of receipt of cash proceeds of $33,320), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90F_ecustom--InitialDerivativeLiability_iI_pp0p0_c20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zlbSdFGJy6xl">36,821, $<span id="xdx_90E_ecustom--DayOneGainOnDerivative_pp0p0_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zhcYKiBzYyv3">2,821 as day one loss on the derivative, $<span id="xdx_908_eus-gaap--InterestExpenseOther_pp0p0_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zgVYpAr9WQqk">6,800 as interest expense, $<span id="xdx_906_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zwrpvSwYaHRl">6,800 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zcb3APgpAvMc">34,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_90E_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zny0o3wiRVb7">7,362 for the year ended December 31, 2025. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_90C_eus-gaap--Dividends_pp0p0_c20250101__20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_z6HKM6B9aSW7">394 for the year ended December 31, 2025. The preferred stock dividend payable to GHS for this derivative totaled $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zlEJGtEPaLL5">394 as of December 31, 2025. The preferred stock dividend payable at December 31, 2025 included $58 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. The derivative liability payable for this transaction totaled $<span id="xdx_90C_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zoOrSWcZPFpe">44,183 as of December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_901_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_z6ZJ21j0dhld">40,800 as of December 31, 2025. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price of $0.0006, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0007 to $0.0008, an expected dividend yield of 0%, expected volatility ranging from 174.48% to 198.95%, risk-free interest rates ranging from 3.48% to 3.59%, and an expected term of 1 year. Series E Preferred Stock On October 30, 2025, the Board of Directors of the Company had authorized issuance of up to 3,000 shares of preferred stock, $0.001 par value per share, designated as Series E Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of 10% per annum, payable quarterly, beginning on the Original Issue Date and ending on the date that such share of Preferred Share has been converted or redeemed. Dividends may be paid in cash or in shares of Preferred Stock, at the Corporation’s discretion. From and after the initial Closing Date, in addition to the payment of dividends, each Holder shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. The Corporation shall pay no dividends on shares of the Common Stock unless it simultaneously complies with the previous sentence. Any dividends that are not paid a Dividend Payment Date shall continue to accrue and shall entail a late fee (“Late Fees”), which must be paid in cash, at the rate of 12% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the Dividend Payment Date through and including the date of actual payment in full. Voting Rights. The Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise pari passu with, the Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise pari passu with, the Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing. Liquidation: Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation. The Corporation shall mail written notice of any such Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder. Conversion: Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to certain limitations) determined by dividing the Stated Value of such share of Preferred Stock by Conversion Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice. Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued. Conversion price: The conversion price for the Preferred Stock shall be a fixed price equal to $0.0005. All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such measuring period. Nothing herein shall limit a Holder’s right to pursue actual damages including, but not limited to, as a result of a Triggering Event pursuant to Section 10 hereof and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. Corporation Redemption: The Corporation shall have the right to redeem, all (but not less than all), shares of the Preferred Stock issued and outstanding at any time after the Original Issue Date, upon three (3) business days’ notice, at a redemption price per Preferred Stock then issued and outstanding (the “Corporation Redemption Price”), equal to the product of (i) the Premium Rate (means 1.10) multiplied by (ii) the sum of (x) the Stated Value, (y) all accrued but unpaid dividends, and (z) all other amount due to the Holder pursuant to this Certificate of Designation and/or any Transaction Document including, but not limited to Late Fees, liquidated damages and the legal fees and expenses of the Holder’s counsel relating to this Certification of Designation, any other Transaction Document and/or the transactions contemplated thereunder and/or hereunder. Notwithstanding the delivery of a Corporation Redemption Notice, a Holder may convert some or all of its shares of Preferred Stock until the date it receives in full Corporation Redemption Price, provided, however, that notwithstanding anything to the contrary provided herein or elsewhere (i) in the event a Holder would be precluded from converting any shares of Preferred Stock, due to the limitation contained in Section 5, the Corporation Redemption Payment Date, for such Holder only, shall automatically be extended by one hundred twenty (120) days (or such shorter period as so provided to the Corporation by the Holder at any time and (ii) if a Mandatory Conversion has occurred prior to the Corporation Redemption Payment Date and for whatever reason including, but not limited to, the Beneficial Ownership Limitation, a Holder still owns Preferred Stock, any such Holder may elect to extend the Corporation Redemption Payment Date as to any or all of such Holder’s Preferred Stock for up to one hundred twenty (120) days following the Corporation Redemption Payment Date to allow such Holder to convert its remaining Preferred Stock into Conversion Shares. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Emmons DEA”) with Clifford L. Emmons, it’s Chief Executive Officer and Director. Pursuant to the Emmons DEA, Mr. Emmons exchanged $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember_znzC5iv55PCb" title="Debt converted, amount converted">387,242 of accrued compensation and unpaid fees owed to him by the Company under various agreements, for <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zPzAR5GJpDdb" title="Debt converted, shares issued">268.529 shares of the Company’s Series E Convertible Preferred Stock (the “Series E Preferred Stock”). In addition to the issuance of the Company’s Series E Preferred Stock, Mr. Emmons agreed to cancel <span id="xdx_907_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zMCSIymGQUb" title="Stock cancelled during period">7,800 shares of Series A Preferred Stock owned by him. The closing of the Emmons DEA occurred on November 5, 2025. The Company recorded $<span id="xdx_90E_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_znMRA2tvzLc3" title="Accrued dividend payable">5,599 as dividend payable to Mr. Emmons as of December 31, 2025. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Mitta DEA”) with Vidhyadhar Mitta, it’s former Director. Pursuant to the Mitta DEA, Mr. Mitta exchanged $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--MittaDEAMember_zXg77nBULDyl" title="Debt converted, amount converted">216,156 of principal and accrued and unpaid interest owed to him by the Company under the 12% Secured Convertible Promissory Note issued to Mr. Mitta on August 2, 2019 for <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--MittaDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zotLyRtXWWce">180 shares of Series E Preferred Stock. In addition to the issuance of the Series E Preferred Stock, Mr. Mitta agreed to cancel <span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--MittaDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zV3ZNUbiB1de" title="Stock cancelled during period">12,000 shares of Series A Preferred Stock owned by him. The closing of the Mitta DEA occurred on November 5, 2025. The Company recorded $<span id="xdx_909_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--MittaDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zHXznAsjCBI4" title="Accrued dividend payable">3,720 as dividend payable to Mr. Mitta as of December 31, 2025. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “McNemar DEA”) with Karen McNemar, it’s former Chief Financial Officer. Pursuant to the McNemar DEA, Ms. McNemar exchanged $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--McNemarDEAMember_zyaiO6uJt899" title="Debt converted, amount converted">323,269 of accrued and unpaid fees owed to her by the Company under various agreements for <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--McNemarDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z0OAVtscY5sg">269 shares of Series E Preferred Stock. In addition to the issuance of the Series E Preferred Stock, Ms. McNemar agreed to cancel <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--McNemarDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zmzrvmuWypwh" title="Stock cancelled during period">6,045 shares of Series A Preferred Stock owned by her. The closing of the McNemar DEA occurred on November 5, 2025. The Company recorded $<span id="xdx_903_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--McNemarDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zBf8aZZugFI6" title="Accrued dividend payable">5,559 as dividend payable to Ms. McNemar as of December 31, 2025. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Senior Secured DEA”) with Sergey Gogin and Yvsgramorah, LLC, an entity controlled by Mr. Gogin (the “Senior Secured Holders”). Pursuant to the Senior Secured DEA, the Senior Secured Holders exchanged an aggregate of $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--SeniorSecuredHoldersMember_zTPa7eiauKc1" title="Debt converted, amount converted">522,195 of principal and accrued and unpaid interest owed to the Senior Secured Holders by the Company under the Senior Secured Convertible Note issued to Mr. Gogin on January 22, 2018 (the “Gogin Note”) and the Senior Secured Convertible Note issued to Yvsgramorah, LLC on March 6, 2019 (the “YVS Note,” together, with the Gogin Note, the “Senior Secured Notes”) for an aggregate of <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--SeniorSecuredHoldersMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z5CgXYaSf0fj">489 shares (the “Senior Secured Shares”) of Series E Preferred Stock. The closing of the Senior Secured DEA occurred on November 5, 2025. The Company recorded $<span id="xdx_906_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20251231__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--SeniorSecuredHoldersMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zNIbZyw5s2E4">10,106 as dividend payable to Mr. Gogin as of December 31, 2025. The following table represents the change in the fair value of the derivative liabilities for the year ended December 31, 2025 and 2024, respectively. <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zNJzm8xxE4lf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Change in the fair value)"> <tr style="vertical-align: bottom"> <td>Schedule of change in the fair value of the derivative liabilities</td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 55%">Balance at December 31, 2023</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwdKqXZ2LHxb" style="width: 11%; text-align: right" title="Derivative liability, Beginning balance">–</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFIg7OpKtnLk" style="width: 11%; text-align: right" title="Derivative liability, Beginning balance">–</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_982_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeFQnFTLtjwf" style="width: 11%; text-align: right" title="Derivative liability, Beginning balance">535,653</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Additions to derivative liability</td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zR3PaBOnTMTg" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqwWe53eizXj" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdINxFBfnmHh" style="text-align: right" title="Additions to derivative liability">111,611</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Change in the fair value of derivative liability</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_988_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1FxCsuQmEyd" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXVw3d66PFKj" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_981_eus-gaap--DerivativeGainLossOnDerivativeNet_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzntiejJB3G8" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">111,523</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at December 31, 2024</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zK52jFiuQ6Vk" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6sx4zjqqrg1" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zP4uIzYnFfy" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">758,787</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at December 31, 2024</td> <td> </td> <td>$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9ZHNYllP5Y9" style="text-align: right" title="Derivative liability, Beginning balance">–</td> <td> </td> <td> </td> <td>$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zUuSg6168QNi" style="text-align: right" title="Derivative liability, Beginning balance">–</td> <td> </td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd9Db2MaLola" style="text-align: right" title="Derivative liability, Beginning balance">758,787</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Additions to derivative liability</td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyEXImi632P8" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0Bra63gS7d3" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4embdYGRHEk" style="text-align: right" title="Additions to derivative liability">233,003</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Change in the fair value of derivative liability</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zehNyexJ7upg" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_za8mNWlnoVuk" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9pLPtRkbub2" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">(40,258</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance at December 31, 2025</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_981_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9YodNlCjgui" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98C_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zkkd0zpCpBx9" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zNPE212KWk3e" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">951,532</td> <td> </td></tr> </table> As a result of issuance of derivative instruments, the Company recorded a derivative liability of $951,532 and $758,787 as of December 31, 2025 and 2024, Series B Convertible Preferred Stock liability of $<span id="xdx_906_ecustom--PreferredStockDerivativeLiability_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zkxxLaWhWTS9" title="Preferred stock derivative liability">699,600 and $694,800 as of December 31, 2025 and 2024, Series C Convertible Preferred Stock liability of $68,400 as of December 31, 2025 and 2024, and Series D Convertible Preferred Stock liability of $252,000 and $0 as of December 31, 2025 and 2024, respectively. Warrants A summary of the status of the Company’s warrants as of December 31, 2025 and 2024, and changes during the nine months then ended, is presented below: <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zX49Pt7gSP4f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Warrants)"> <tr style="vertical-align: bottom"> <td style="text-align: left">Schedule of warrant activity</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Shares Under Warrants</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contractual Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Outstanding at December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20240101__20241231_zGw5TjWrkRHj" style="width: 11%; text-align: right" title="Shares under warrants outstanding, beginning balance">2,868,397</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20240101__20241231_zUIFPoZUJez9" style="width: 11%; text-align: right" title="Weighted average exercise price outstanding, beginning balance">0.00084</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231_z7KoMXFWuJd4" title="Weighted average remaining contractual life">0.4 Years</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240101__20241231_zFJeH4qiGNN8" style="text-align: right" title="Shares under warrants, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240101__20241231_zasdxnU6ooV7" style="text-align: right" title="Weighted average exercise price, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left">Expired/Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20241231_zTCOxhNz3kyf" style="border-bottom: Black 1pt solid; text-align: right" title="Shares under warrants, expired/forfeited">(2,868,397</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20240101__20241231_zrIy2EAK0eVc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20240101__20241231_zYMtA8kGxPPi" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares under warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20240101__20241231_zmtTO7AzKj2j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Outstanding at December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20250101__20251231_z8O1TtlDi1dh" style="text-align: right" title="Shares under warrants outstanding, beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20250101__20251231_zOZgkYzknfn9" style="text-align: right" title="Weighted average exercise price outstanding, beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20250101__20251231_zQMfLoIKRTPh" style="text-align: right" title="Shares under warrants, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20251231_zbFSnEdbfo6" style="text-align: right" title="Weighted average exercise price, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left">Expired/Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di0_c20250101__20251231_zdgQHQyx58M6" style="border-bottom: Black 1pt solid; text-align: right" title="Shares under warrants, expired/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20250101__20251231_zxyEhsixRoU8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: left">Outstanding at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20250101__20251231_zahrDdqlvRL8" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares under warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20250101__20251231_zRc95Zprm6zk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

10000000000

0.001

10000000

0.001

586285063

100

583

210

1207

11500000 5750 8469770 4235

4500000

952212

5000000

200000

240

3530000

1470000

20000000

14300000

14200000 6000000

100000

5000000

100000

6120

6000000

5400

14300000

3728

3413

4734247

4515068

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z0TlnxLCZSRi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Non-vested shares)"> <tr style="vertical-align: bottom"> <td style="display: none">Schedule of non-vested shares</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">2022 Stock Incentive Plan</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Shares of Common Stock</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Authorized shares per the 2022 Plan – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLSE9MREVSUycgRVFVSVRZIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zEsTV4kxz7G6" title="Authorized shares">20,000,000 shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%">Balance - December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zTw8CyMg8YWd" style="width: 13%; text-align: right" title="Shares of common stock, Beginning balance">14,300,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zeB5aKFmaHCl" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Awarded and issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zzhXGnEXpfTh" style="text-align: right" title="Shares of common stock, Awarded">3,100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zEsUDl998Cu2" style="text-align: right" title="Weighted average exercise price, Awarded">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zUq7qM7nVAJ" style="text-align: right" title="Shares of common stock, Vested">(8,100,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z6dr164ZfCw8" style="text-align: right" title="Weighted average exercise price, Vested">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zrlcYRXFwHig" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zbk895HtnE84" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Balance – December 31, 2024 – (Vested)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zCDBBJulglw2" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Vested">9,300,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z7SCgQ9F5sP5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Vested">0.006146</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance – December 31, 2024 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zlHSB5SUz3ra" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">6,100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20240101__20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zJ6HASQpoMa6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Balance - December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zdcEgSHPo4G6" style="text-align: right" title="Shares of common stock, Beginning balance">9,300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zQ6tmvA7UnV9" style="text-align: right" title="Weighted average exercise price, Beginning balance">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Awarded</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z68yoQPSU0K1" style="text-align: right" title="Shares of common stock, Awarded">11,100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zJgiWMOF7QSg" style="text-align: right" title="Weighted average exercise price, Awarded">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zsx7rZUoNWPk" style="text-align: right" title="Shares of common stock, Vested">(14,300,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zGgO918HrV53" style="text-align: right" title="Weighted average exercise price, Vested">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zQ717ySuw2J9" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">6,000,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zKk9cFE7E5Mf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Balance – December 31, 2025 – (Vested)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zJ7dlCWq6S5d" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Vested">100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z9OCF2tWhc5i" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Vested">0.006146</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance – December 31, 2025 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_d0_c20250101__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zlVJncerWDu7" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_d0_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z48txTyEO9jj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

20000000

14300000

3100000

0.006146

8100000

9300000

0.006146

6100000

9300000

0.006146

11100000

14300000

0.006146

6000000

100000

0.006146

25845

0.001

100

7800

12000

6045

100

25845

600

0.001

45000

900

103267 58267

39000

45000

9132 14783

179540

41508

78317 87450 84000 84000

85000

1700

106241 21241

17000

85000

11089 17950

166478

12274

215975

49497

95099 106189 102000 102000

51000

1000

6654 10770

66997

7364

89270

22273

57060 63713 61200 61200

51000

1000

65025 14025

10200

51000

6654 10770

61759

7364

83045

21288

57060 63713 61200 61200

136

136000

2720

328422 192422

27200

136000

17743 28720

151147

19638

205500

54352

152159 169902 163200 163200

61000

1220

54072 6928

12200

61000

7958 12882

56348

8808

74999

18651

68248 76206 73200 73200

62000

1240

61679 321

12400

62000

8144 13100

50373

8952

62481

12108

69367 77511

17600

2400

20324 321

4000

24000

20000

2419 1965

7766

2044

9810

2044

19870 22289 24000 24000

43000

3860

43000 11480

8600

51600

39140

5685 2951

15399

1650

17049

1650

646694 52378 56400 56400

5000

1200

55000

13825

40668

425

68825

68825 9721 3226

19471

6859

26330

6859

39223 43894 68400 68400

210

1200

60000

9200

65024 14224

12000

72000

50800

12946

14374

77970 72000

45000

900

57220 12220

9000

54000

45000

1257

5193

58477 54000

11000

220

13815 2815

2200

13815

11000

479

1111

14294 13200

25000

500

31399 6399

5000

13815

11000

1089

2526

32487 30000

35000

700

28724 6276

7000

35000

16758

1099

45482 42000

34000

680

36821 2821

6800

34000

7362

394

44183 40800

3000

1200

387242

268

7800

5599

216156

180

12000

3720

323269

269

6045

5559

522195

489

10106

<table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zNJzm8xxE4lf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Change in the fair value)"> <tr style="vertical-align: bottom"> <td>Schedule of change in the fair value of the derivative liabilities</td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Level 3</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 55%">Balance at December 31, 2023</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zwdKqXZ2LHxb" style="width: 11%; text-align: right" title="Derivative liability, Beginning balance">–</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zFIg7OpKtnLk" style="width: 11%; text-align: right" title="Derivative liability, Beginning balance">–</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td id="xdx_982_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zeFQnFTLtjwf" style="width: 11%; text-align: right" title="Derivative liability, Beginning balance">535,653</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Additions to derivative liability</td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zR3PaBOnTMTg" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqwWe53eizXj" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdINxFBfnmHh" style="text-align: right" title="Additions to derivative liability">111,611</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Change in the fair value of derivative liability</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_988_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1FxCsuQmEyd" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zXVw3d66PFKj" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_981_eus-gaap--DerivativeGainLossOnDerivativeNet_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzntiejJB3G8" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">111,523</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at December 31, 2024</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zK52jFiuQ6Vk" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6sx4zjqqrg1" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20240101__20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zP4uIzYnFfy" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">758,787</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Balance at December 31, 2024</td> <td> </td> <td>$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9ZHNYllP5Y9" style="text-align: right" title="Derivative liability, Beginning balance">–</td> <td> </td> <td> </td> <td>$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zUuSg6168QNi" style="text-align: right" title="Derivative liability, Beginning balance">–</td> <td> </td> <td> </td> <td>$</td> <td id="xdx_98D_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd9Db2MaLola" style="text-align: right" title="Derivative liability, Beginning balance">758,787</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Additions to derivative liability</td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyEXImi632P8" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0Bra63gS7d3" style="text-align: right" title="Additions to derivative liability">–</td> <td> </td> <td> </td> <td> </td> <td id="xdx_98D_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4embdYGRHEk" style="text-align: right" title="Additions to derivative liability">233,003</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Change in the fair value of derivative liability</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zehNyexJ7upg" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_za8mNWlnoVuk" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9pLPtRkbub2" style="border-bottom: black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">(40,258</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance at December 31, 2025</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_981_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9YodNlCjgui" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_98C_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zkkd0zpCpBx9" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td id="xdx_987_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zNPE212KWk3e" style="border-bottom: black 2.25pt double; text-align: right" title="Derivative liability, Ending balance">951,532</td> <td> </td></tr> </table>

535653

111611

111523

758787

233003

-40258

951532

758787

699600 694800 68400 68400 252000 0

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zX49Pt7gSP4f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Warrants)"> <tr style="vertical-align: bottom"> <td style="text-align: left">Schedule of warrant activity</td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Shares Under Warrants</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Remaining Contractual Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Outstanding at December 31, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20240101__20241231_zGw5TjWrkRHj" style="width: 11%; text-align: right" title="Shares under warrants outstanding, beginning balance">2,868,397</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20240101__20241231_zUIFPoZUJez9" style="width: 11%; text-align: right" title="Weighted average exercise price outstanding, beginning balance">0.00084</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231_z7KoMXFWuJd4" title="Weighted average remaining contractual life">0.4 Years</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240101__20241231_zFJeH4qiGNN8" style="text-align: right" title="Shares under warrants, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240101__20241231_zasdxnU6ooV7" style="text-align: right" title="Weighted average exercise price, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left">Expired/Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20241231_zTCOxhNz3kyf" style="border-bottom: Black 1pt solid; text-align: right" title="Shares under warrants, expired/forfeited">(2,868,397</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20240101__20241231_zrIy2EAK0eVc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Outstanding at December 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20240101__20241231_zYMtA8kGxPPi" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares under warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20240101__20241231_zmtTO7AzKj2j" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Outstanding at December 31, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20250101__20251231_z8O1TtlDi1dh" style="text-align: right" title="Shares under warrants outstanding, beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20250101__20251231_zOZgkYzknfn9" style="text-align: right" title="Weighted average exercise price outstanding, beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20250101__20251231_zQMfLoIKRTPh" style="text-align: right" title="Shares under warrants, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20250101__20251231_zbFSnEdbfo6" style="text-align: right" title="Weighted average exercise price, issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left">Expired/Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di0_c20250101__20251231_zdgQHQyx58M6" style="border-bottom: Black 1pt solid; text-align: right" title="Shares under warrants, expired/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20250101__20251231_zxyEhsixRoU8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-align: left">Outstanding at December 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20250101__20251231_zahrDdqlvRL8" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares under warrants outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20250101__20251231_zRc95Zprm6zk" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding, ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2868397

0.00084

P0Y4M24D

2868397

-0

NOTE 9 – INCOME TAXES The following is a reconciliation of the statutory federal income tax rate to the effective tax rate reported in the financial statements for the years ended December 31, 2025 and 2024, respectively: <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zf8aFwm1bod5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - reconcilation of income tax)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Reconciliation of income tax rate</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">2024</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; font-size: 10pt; text-align: left">US Federal statutory rate</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYNEzyM272tj" style="width: 11%; font-size: 10pt; text-align: right" title="US Federal statutory rate">302,665</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zEFXNx0jVXbk" style="width: 11%; font-size: 10pt; text-align: right" title="US Federal statutory rate">21.00%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zvKLhplVEWJd" style="width: 11%; font-size: 10pt; text-align: right" title="US Federal statutory rate">160,577</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zyIZY3gk5IB8" style="width: 11%; font-size: 10pt; text-align: right">21.00%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Effects of:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">State and local taxes, net of federal benefits</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zQY86jqykdM" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">69,901</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zFDA7ufMxUnj" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">4.85%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zDjpLOaHGXZd" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">33,722</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zIIwtAmzpsEj" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">4.85%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Other permanent items</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_z2ouwWE8Qadg" style="font-size: 10pt; text-align: right" title="Other permanent items">(9,656</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_989_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zXkvRAYvBZV5" style="font-size: 10pt; text-align: right" title="Other permanent items">(0.67%</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zhpkVpPjjkUe" style="font-size: 10pt; text-align: right" title="Other permanent items">3,364</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zGSILKVmWg6d" style="font-size: 10pt; text-align: right" title="Other permanent items">0.44%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Change in valuation allowance</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zSQdGlZdO3m" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">(362,910</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zBMQgbdsJbi3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">25.18%</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zlSScLYVxon7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">(197,663</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_z0jM2sdXRXi2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">26.29%</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Tax expense at actual rate</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20251231_z9uK8CTB8VPe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">–</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20250101__20251231_zPl42Yke7Cwj" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">0.00%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_d0_c20240101__20241231_z9SWbgt9kQqi" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">–</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240101__20241231_zuR2N3b4Lb26" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">0.00%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> The tax effects of temporary differences that gave rise to significant portions of deferred tax assets and liabilities at December 31, 2025 and 2024 are as follows: <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zBfoswxDJCi9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Deferred tax assets)"> <tr style="vertical-align: bottom"> <td>Schedule of deferred tax assets and liabilities</td> <td> </td> <td colspan="3" id="xdx_492_20251231_zptdTOZ7FUG3" style="text-align: center"> </td> <td> </td> <td colspan="3" id="xdx_495_20241231_zu5enHrwR9ej" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, 2025</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, 2024</td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxesAbstract_iB" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Deferred tax assets:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGz1Ds_zarts5Cvs6Ri" style="vertical-align: bottom; background-color: white"> <td style="width: 66%">Net operating loss carry forward</td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%">$</td> <td style="border-bottom: black 1pt solid; width: 13%; text-align: right">3,270,366</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%">$</td> <td style="border-bottom: black 1pt solid; width: 13%; text-align: right">2,897,800</td> <td style="width: 1%"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGz1Ds_maDTANzbNv_zv644gRRzkJc" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Total gross deferred tax assets</td> <td> </td> <td> </td> <td style="text-align: right">3,270,366</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,897,800</td> <td> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzbNv_z6tfx1IZEILg" style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Less: valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(3,270,366</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2,897,800</td> <td style="padding-bottom: 1pt">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANzbNv_zMfpqUHgPCIa" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Net deferred tax assets</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">–</td> <td> </td></tr> </table> Deferred income taxes are provided for the tax effects of transactions reported in the financial statements and consist of deferred taxes related primarily to differences between the bases of certain assets and liabilities for financial and tax reporting. The deferred taxes represent the future tax return consequences of those differences, which will either be deductible or taxable when the assets and liabilities are recovered or settled. At December 31, 2025 and 2024, the Company had accumulated net operating losses of approximately $12,450,000 and $11,208,000, respectively, for U.S. federal and Massachusetts income tax purposes available to offset future taxable incomes. The net operating losses generated in tax years prior to December 31, 2017, can carry forward for 20 years, whereas the net operating losses generated after December 31, 2017 can carry forward indefinitely. Management determined that it was unlikely that the Company’s deferred tax assets would be realized and have provided for a full valuation allowance associated with the net deferred tax assets. In the ordinary course of business, the Company’s income tax returns are subject to examination by various taxing authorities. Such examinations may result in future tax and interest assessment by these taxing authorities. Accordingly, the Company believes that it is more likely than not that it will realize the benefits of tax positions it has taken in its tax returns or for the amount of any tax benefit that exceeds the cumulative probability threshold in accordance with FASB ASC 740. Differences between the estimated and actual amounts determined upon ultimate resolution, individually or in the aggregate, are not expected to have a material adverse effect on the Company’s financial position. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for unrecognized tax benefits. The Company is delinquent in filing its Federal and State income tax returns for the years ended December 31, 2022, 2023, 2024, and 2025. As of December 31, 2025, tax years 2025, 2024, 2023, and 2022 remain open for examination by the Internal Revenue Service and the Massachusetts Division of Revenue. The Company has received no notice of audit from the Internal Revenue Service or the Massachusetts Division of Revenue for any of the open tax years.

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zf8aFwm1bod5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - reconcilation of income tax)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Reconciliation of income tax rate</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">2025</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">2024</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; font-size: 10pt; text-align: left">US Federal statutory rate</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYNEzyM272tj" style="width: 11%; font-size: 10pt; text-align: right" title="US Federal statutory rate">302,665</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zEFXNx0jVXbk" style="width: 11%; font-size: 10pt; text-align: right" title="US Federal statutory rate">21.00%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zvKLhplVEWJd" style="width: 11%; font-size: 10pt; text-align: right" title="US Federal statutory rate">160,577</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zyIZY3gk5IB8" style="width: 11%; font-size: 10pt; text-align: right">21.00%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Effects of:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">State and local taxes, net of federal benefits</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zQY86jqykdM" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">69,901</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zFDA7ufMxUnj" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">4.85%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zDjpLOaHGXZd" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">33,722</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98C_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zIIwtAmzpsEj" style="font-size: 10pt; text-align: right" title="State and local taxes, net of federal benefits">4.85%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Other permanent items</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_z2ouwWE8Qadg" style="font-size: 10pt; text-align: right" title="Other permanent items">(9,656</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_989_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zXkvRAYvBZV5" style="font-size: 10pt; text-align: right" title="Other permanent items">(0.67%</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_982_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zhpkVpPjjkUe" style="font-size: 10pt; text-align: right" title="Other permanent items">3,364</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zGSILKVmWg6d" style="font-size: 10pt; text-align: right" title="Other permanent items">0.44%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">Change in valuation allowance</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zSQdGlZdO3m" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">(362,910</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td id="xdx_984_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20250101__20251231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zBMQgbdsJbi3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">25.18%</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_zlSScLYVxon7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">(197,663</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="padding-bottom: 1pt; font-size: 10pt"> </td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240101__20241231__us-gaap--IncomeTaxAuthorityAxis__custom--IncomeTaxReconciliationMember_z0jM2sdXRXi2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in valuation allowance">26.29%</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">Tax expense at actual rate</td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20251231_z9uK8CTB8VPe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">–</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20250101__20251231_zPl42Yke7Cwj" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">0.00%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_d0_c20240101__20241231_z9SWbgt9kQqi" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">–</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; font-size: 10pt"> </td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td id="xdx_981_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240101__20241231_zuR2N3b4Lb26" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Tax expense at actual rate">0.00%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table>

302665

0.2100

160577

0.2100

69901

0.0485

33722

0.0485

-9656

-0.0067

3364

0.0044

-362910

0.2518

-197663

0.2629

0.0000

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zBfoswxDJCi9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Deferred tax assets)"> <tr style="vertical-align: bottom"> <td>Schedule of deferred tax assets and liabilities</td> <td> </td> <td colspan="3" id="xdx_492_20251231_zptdTOZ7FUG3" style="text-align: center"> </td> <td> </td> <td colspan="3" id="xdx_495_20241231_zu5enHrwR9ej" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, 2025</td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">December 31, 2024</td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxesAbstract_iB" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Deferred tax assets:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGz1Ds_zarts5Cvs6Ri" style="vertical-align: bottom; background-color: white"> <td style="width: 66%">Net operating loss carry forward</td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%">$</td> <td style="border-bottom: black 1pt solid; width: 13%; text-align: right">3,270,366</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%">$</td> <td style="border-bottom: black 1pt solid; width: 13%; text-align: right">2,897,800</td> <td style="width: 1%"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGz1Ds_maDTANzbNv_zv644gRRzkJc" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Total gross deferred tax assets</td> <td> </td> <td> </td> <td style="text-align: right">3,270,366</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,897,800</td> <td> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzbNv_z6tfx1IZEILg" style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Less: valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(3,270,366</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2,897,800</td> <td style="padding-bottom: 1pt">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANzbNv_zMfpqUHgPCIa" style="vertical-align: bottom; background-color: #EEEEEE"> <td>Net deferred tax assets</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">–</td> <td> </td></tr> </table>

3270366

2897800

3270366

2897800

3270366

2897800

12450000

11208000

NOTE 10 – SUBSEQUENT EVENTS On March 6, 2026, the Company entered into a Securities Purchase Agreement ( “SPA”) with GHS Investments for the purchase and sale of up to 97 shares of the Company’s Series D Preferred Stock for an aggregate purchase price of up to $88,000. On March 12, 2026, pursuant to the SPA, the Company issued to GHS Investments 43 shares of Series D Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $40,140. The Company paid sales commissions of $860 and $2,000 in legal fees to complete this sale transaction. On March 23, 2026, the Company issued 100,000 shares of its common stock, fully vested, to a consultant pursuant to 2022 Plan (Note 8). On April 10, 2026, the Board of Directors adopted a resolution to terminate the company’s three equity compensation plans: the 2017 Stock Incentive Plan (the "2017 Plan"), the 2019 Stock Incentive Plan (the "2019 Plan"), and the 2022 Stock Incentive Plan (the "2022 Plan"). Each of the Plans was terminated effective December 31, 2025. On April 16, 2026, the Board of Directors adopted a resolution to approve and authorize an amendment to the Original Certificate of Designation for Series D to increase the total number of authorized shares of Series D Preferred Stock from 210 shares to 500 shares. On April 21, 2026, GHS Investments entered into a financing arrangement and purchased 45 shares of Series D Convertible Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $43,100, The Company paid sales commissions of $900 and $1,000 in legal fees to complete this sale transaction. Management evaluated all subsequent events through the date of filing.